{"content":"<li class=\"n-box-item date-title\" data-end=\"1543899599\" data-start=\"1543813200\" data-txt=\"Monday, December 23, 2019\">Monday, December  3, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3414129\" data-ts=\"1543876611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414129-apa-crus-and-rh-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">APA, CRUS and RH among notable after hour movers</a></h4><ul> <li>\n<strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color=\"green\">+20.2%</font>. <a href='https://seekingalpha.com/symbol/AMS' title='American Shared Hospital Services'>AMS</a> <font color=\"green\">+8.0%</font>. <a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet'>SMAR</a> <font color=\"green\">+7.7%</font>. <a href='https://seekingalpha.com/symbol/LOMA' title='Loma Negra Compania Industrial Argentina Sociedad  ADS'>LOMA</a> <font color=\"green\">+3.9%</font>. <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color=\"green\">+3.3</font><font color=\"green\">%</font>.</li> <li>\n<strong>Losers: </strong><a href='https://seekingalpha.com/symbol/OSBC' title='Old Second Bancorp, Inc.'>OSBC</a> <font color=\"red\">-9.9%</font>. <a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color=\"red\">-4.3%</font>. <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color=\"red\">-3.5%</font>.<a href='https://seekingalpha.com/symbol/TLND' title='Talend SA'>TLND</a> <font color=\"red\">-2.6%</font>. <a href='https://seekingalpha.com/symbol/LSCC' title='Lattice Semiconductor Corporation'>LSCC</a> <font color=\"red\">-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414129\" data-linked=\"APA, CRUS and RH among notable after hour movers\" data-tweet=\"$RH $RH $AMS - APA, CRUS and RH among notable after hour movers https://seekingalpha.com/news/3414129-apa-crus-and-rh-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3414129-apa-crus-and-rh-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414126\" data-ts=\"1543875892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414126-momo-draws-short-pitch-kase-conference\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momo draws short pitch at Kase conference</a></h4><ul>   <li>J Capital warns of \"circular revenues\" in a short pitch for Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>) at the Kase Learning Short-Selling Conference.</li>    <li>Anne Stevenson-Yang says the company exemplifies \"virtual revenues\" in China, noting much of the strong revenue growth is driven by customers who pay the company but get some 75%-100% of the cash back -- an approach she notes  could be used for money laundering. The firm estimates that aspect could affect some 40% of revenues.</li>    <li>Meanwhile the company is painting a picture of growing monthly active users and growth potential, whereas J Capital says MAUs peaked a year ago and the company faces a crowded industry along with high political risk and massive insider selling.</li>    <li>Management has turned over (three top members resigned for personal reasons on the same day in November 2017), and a tightening of the money supply in 2019 could prove a negative catalyst as it did in 2009-2010 (a year that took out gaming companies like Giant Interactive, Perfect World, The9 and Shanda).</li>    <li>The firm sees 41% downside, to $18.62; shares <font color=\"green\">rose 5.5%</font> today to reach $33.08. They're <font color=\"red\">down 0.2%</font> after hours.</li> <li>#KaseLearning</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3413889-momo-moves-call-due-wednesday-market-closing\" target=\"_blank\">Momo moves call due to Wednesday market closing</a> (Dec. 03 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414126\" data-linked=\"Momo draws short pitch at Kase conference\" data-tweet=\"$MOMO - Momo draws short pitch at Kase conference https://seekingalpha.com/news/3414126-momo-draws-short-pitch-kase-conference?source=tweet\" data-url=\"https://seekingalpha.com/news/3414126-momo-draws-short-pitch-kase-conference\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414115\" data-ts=\"1543874175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414115-cirrus-logicminus-6-on-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cirrus Logic -6% on guidance cut</a></h4><ul>\n<li>Cirrus Logic (NASDAQ:<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a>) drops 6% aftermarket on <a href=\"https://seekingalpha.com/pr/17347836-cirrus-logic-updates-third-quarter-fiscal-2019-outlook\" target=\"_blank\">lowering</a> its Q3 revenue guidance to between $300M and $340M (was: $360M to $400M) due to weakness in the smartphone market.</li>\n<li>Cirrus' guidance cut follows those of fellow Apple suppliers Lumentum and Qorvo, who were among several names cutting forecasts last month.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414115\" data-linked=\"Cirrus Logic -6% on guidance cut\" data-tweet=\"$CRUS - Cirrus Logic -6% on guidance cut https://seekingalpha.com/news/3414115-cirrus-logicminus-6-on-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3414115-cirrus-logicminus-6-on-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414114\" data-ts=\"1543874050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UDR\" target=\"_blank\">UDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414114-udr-slips-1_2-after-announcing-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UDR slips 1.2% after announcing stock offering</a></h4><ul>\n<li>UDR (NYSE:<a href='https://seekingalpha.com/symbol/UDR' title='UDR, Inc.'>UDR</a>) <font color=\"red\">slumps 1.2%</font> in after-hours trading after agreeing <a href=\"https://seekingalpha.com/pr/17347852-udr-announces-public-offering-common-stock\" target=\"_blank\">to sell 7.15M shares </a>of common stock in a public offering.</li>\n<li>Plans to use proceeds for planned acquisitions of assets, working capital, and general corporate purposes.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3402301-udr-ffo-line-beats-revenue\" target=\"_blank\">UDR FFO in-line, beats on revenue</a> (Oct. 29)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414114\" data-linked=\"UDR slips 1.2% after announcing stock offering\" data-tweet=\"$UDR - UDR slips 1.2% after announcing stock offering https://seekingalpha.com/news/3414114-udr-slips-1_2-after-announcing-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3414114-udr-slips-1_2-after-announcing-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414099\" data-ts=\"1543872563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414099-smartsheetplus-2_9-on-q3-beats-upside-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smartsheet +2.9% on Q3 beats, upside guide</a></h4><ul>\n<li>Smartsheet (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet'>SMAR</a>) <font color=\"green\">gains 2.9%</font> aftermarket on Q3 results that beat EPS and revenue estimates with a 60% Y/Y revenue growth. Upside Q4 guidance has revenue from $49M to $50M (consensus: $45.67M) and EPS from -$0.15 to -$0.13 (consensus: -$0.17).</li>\n<li>Revenue breakdown: Subscription, $41.5M; Professional services, $5.3M.</li>\n<li>Customers: Total was 77,893 at the end of the quarter compared to 76,693 at the end of Q2. The number of customers with ACV at $50K or more was up from 298 to 360. Average ACVs per domain-based customer was up to $2,214 from $2,002.</li>\n<li>Earnings call is scheduled for 4:30 PM ET with a webcast available <a href=\"https://investors.smartsheet.com/home/default.aspx\" target=\"_blank\">here</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/pr/17347779-smartsheet-inc-announces-third-quarter-fiscal-year-2019-results\" target=\"_blank\">Press release</a>.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3414078-smartsheet-beats-0_07-beats-revenue\" target=\"_blank\">Smartsheet beats by $0.07, beats on revenue</a> (Dec. 3)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414099\" data-linked=\"Smartsheet +2.9% on Q3 beats, upside guide\" data-tweet=\"$SMAR - Smartsheet +2.9% on Q3 beats, upside guide https://seekingalpha.com/news/3414099-smartsheetplus-2_9-on-q3-beats-upside-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3414099-smartsheetplus-2_9-on-q3-beats-upside-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414098\" data-ts=\"1543872354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRAC\" target=\"_blank\">FRAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414098-keane-group-announces-5_25m-share-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keane Group announces 5.25M-share secondary offering</a></h4><ul>\n<li>Keane Group (NYSE:<a href='https://seekingalpha.com/symbol/FRAC' title='Keane Group'>FRAC</a>) <font color=\"red\">-5.4%</font> after-hours on news of a <a href=\"https://seekingalpha.com/pr/17347788-keane-announces-public-secondary-offering-selling-stockholder\" target=\"_blank\">secondary offering</a> by shareholder Keane Investor Holdings of ~5.25M common shares, of which FRAC plans to repurchase 520K shares from the underwriter.</li>\n<li>All proceeds from the offering will be       distributed to Trican Well Service, after which Trican (<a href='https://seekingalpha.com/symbol/TOLWF' title='Trican Well Service Ltd.'>OTCPK:TOLWF</a>) will no longer hold equity interests in Keane Investor Holdings.</li>\n<li>FRAC will not receive any proceeds from the offering.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414098\" data-linked=\"Keane Group announces 5.25M-share secondary offering\" data-tweet=\"$FRAC $NEX $TOLWF - Keane Group announces 5.25M-share secondary offering https://seekingalpha.com/news/3414098-keane-group-announces-5_25m-share-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3414098-keane-group-announces-5_25m-share-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414091\" data-ts=\"1543872001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COUP\" target=\"_blank\">COUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414091-coupa-software-reports-q3-beats-upside-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coupa Software reports Q3 beats, upside guide</a></h4><ul>\n<li>Coupa Software (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Inc'>COUP</a>) reports Q3 results that beat EPS and revenue estimates with $0.08 and $67.46M (+43% Y/Y), respectively. Upside Q4 guidance has revenue from $67.8M to $68.3M (consensus: $64.1M) and EPS of about breakeven compared to the -$0.09 consensus.</li>\n<li>Revenue breakdown: Subscription service, $60.6M (consensus $57.1M); Professional services, $6.9M (consensus $5.5M).</li>\n<li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"http://investors.coupa.com/phoenix.zhtml?c=254436&amp;p=irol-irhome\" target=\"_blank\">here</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/pr/17347775-coupa-software-reports-financial-results-third-quarter-fiscal-2019\" target=\"_blank\">Press release</a>.</li>\n<li>Coupa shares are <font color=\"green\">up 0.3%</font> aftermarket and closed today <font color=\"green\">up 6.8%</font>.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3414071-coupa-software-beats-0_11-beats-revenue\" target=\"_blank\">Coupa Software beats by $0.11, beats on revenue</a> (Dec. 3)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414091\" data-linked=\"Coupa Software reports Q3 beats, upside guide\" data-tweet=\"$COUP - Coupa Software reports Q3 beats, upside guide https://seekingalpha.com/news/3414091-coupa-software-reports-q3-beats-upside-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3414091-coupa-software-reports-q3-beats-upside-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414090\" data-ts=\"1543871887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414090-momenta-pharma-to-delap-filing-u-s-marketing-application-for-humira-biosimilar-shares-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momenta Pharma to delap filing U.S. marketing application for Humira biosimilar; shares down 1% after hours</a></h4><ul>\n<li>Citing its recent license deal with AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) that allows it to launch its Humira biosimilar M923 in the U.S. as early as November 20, 2023, Momenta Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MNTA' title='Momenta Pharmaceuticals, Inc.'>MNTA</a>) will <a href=\"https://seekingalpha.com/pr/17347769-momenta-pharmaceuticals-provides-update-us-regulatory-strategy-m923-proposed-biosimilar\" target=\"_blank\">delay filing</a> its marketing application in order to conserve resources. It says the action will not delay its planned market entry in 2023.</li>\n<li>Shares are down <font color=\"red\">1%</font> after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414090\" data-linked=\"Momenta Pharma to delap filing U.S. marketing application for Humira biosimilar; shares down 1% after hours\" data-tweet=\"$ABBV $ABBV $MNTA - Momenta Pharma to delap filing U.S. marketing application for Humira biosimilar; shares down 1% after hours https://seekingalpha.com/news/3414090-momenta-pharma-to-delap-filing-u-s-marketing-application-for-humira-biosimilar-shares-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3414090-momenta-pharma-to-delap-filing-u-s-marketing-application-for-humira-biosimilar-shares-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414088\" data-ts=\"1543871797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414088-rhplus-12-after-strong-q4-guidance-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH +12% after strong Q4, guidance lift</a></h4><ul>\n<li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) is <font color=\"green\">up 12%</font> in AH trading after a sizable Q3 earnings beat. Shares were up 6.5% during the regular session.</li>\n<li>The retailer reported an operating margin improvement of 220 bps to 10.3% of sales. RH's gross margin also topped estimates.</li>\n<li>Comparable brand revenue was up 4% during the quarter.</li>\n<li>RH lifts Q4 revenue guidance to a range of $680M to $690M vs. $665M to $685M prior and EPS of $2.75 to $2.90 vs. prior of guidance $2.33 to $2.54 and $2.50 consensus.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3414073-rh-beats-0_46-beats-revenue\" target=\"_blank\">RH beats by $0.46, beats on revenue</a> (Dec. 3)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414088\" data-linked=\"RH +12% after strong Q4, guidance lift\" data-tweet=\"$RH - RH +12% after strong Q4, guidance lift https://seekingalpha.com/news/3414088-rhplus-12-after-strong-q4-guidance-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3414088-rhplus-12-after-strong-q4-guidance-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414080\" data-ts=\"1543871594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414080-bofa-reiterates-51-upside-for-ttwo-saying-fears-are-overblown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA reiterates 51% upside for TTWO, saying fears are overblown</a></h4><ul>   <li>BofA Merrill Lynch is <a href=\"https://www.barrons.com/articles/take-two-red-dead-online-fears-may-be-overblown-1543869525?mod=hp_LATEST\" target=\"_blank\">sticking with its bullishness</a> on Take-Two Interactive (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>), saying worries about monetizing its latest flagship release, <i>Red Dead Redemption 2,</i> are overblown.</li>    <li>Analyst Justin Post points to a familiar and lucrative example as a model: The company took 18 months for its <i>Grand Theft Auto Online,</i> now a reliable revenue generator, to \"get right.\"</li>    <li>RDR 2 is just in beta, and though \"there have been issues on online game mechanics and rewards raised in the press,\" it will be improved, he notes; there's no genre-specific reasons why the western game can't monetize as well as <i>Grand Theft Auto V.</i>\n</li>    <li>He reiterated a target of $156 for shares; after a <font color=\"red\">5.7% decline</font> today, that implies 51% upside.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3413660-videogame-sales-rise-24-percent-q3-summary-look\" target=\"_blank\">Videogame sales rise 24% in Q3 summary look</a> (Nov. 30 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414080\" data-linked=\"BofA reiterates 51% upside for TTWO, saying fears are overblown\" data-tweet=\"$TTWO - BofA reiterates 51% upside for TTWO, saying fears are overblown https://seekingalpha.com/news/3414080-bofa-reiterates-51-upside-for-ttwo-saying-fears-are-overblown?source=tweet\" data-url=\"https://seekingalpha.com/news/3414080-bofa-reiterates-51-upside-for-ttwo-saying-fears-are-overblown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414078\" data-ts=\"1543871533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414078-smartsheet-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smartsheet beats by $0.07, beats on revenue</a></h4><ul>\n<li>Smartsheet (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet'>SMAR</a>): Q3 Non-GAAP EPS of -$0.09 <span style=\"color:green\">beats by $0.07</span>; GAAP EPS of -$0.15 <span style=\"color:green\">beats by $0.05</span>.</li>\n<li>Revenue of $46.87M (+59.5% Y/Y) <font color=\"green\">beats by $2.75M</font>.</li>\n<li>Shares <font color=\"green\">+1.26%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17347779-smartsheet-inc-announces-third-quarter-fiscal-year-2019-results\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414078\" data-linked=\"Smartsheet beats by $0.07, beats on revenue\" data-tweet=\"$SMAR - Smartsheet beats by $0.07, beats on revenue https://seekingalpha.com/news/3414078-smartsheet-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3414078-smartsheet-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414073\" data-ts=\"1543871283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414073-rh-beats-0_46-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH beats by $0.46, beats on revenue</a></h4><ul>\n<li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>): Q3 Non-GAAP EPS of $1.73 <span style=\"color:green\">beats by $0.46</span>; GAAP EPS of $0.81 <span style=\"color:red\">misses by $0.44</span>.</li>\n<li>Revenue of $636.56M (+7.4% Y/Y) <font color=\"green\">beats by $4.57M</font>.</li>\n<li>Shares <font color=\"green\">+6%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17347773-rh-reports-record-third-quarter-fiscal-2018-results\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414073\" data-linked=\"RH beats by $0.46, beats on revenue\" data-tweet=\"$RH - RH beats by $0.46, beats on revenue https://seekingalpha.com/news/3414073-rh-beats-0_46-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3414073-rh-beats-0_46-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414071\" data-ts=\"1543871257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COUP\" target=\"_blank\">COUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414071-coupa-software-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coupa Software beats by $0.11, beats on revenue</a></h4><ul>\n<li>Coupa Software (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Inc'>COUP</a>): Q3 Non-GAAP EPS of $0.08 <span style=\"color:green\">beats by $0.11</span>; GAAP EPS of -$0.17 <span style=\"color:green\">beats by $0.20</span>.</li>\n<li>Revenue of $67.46M (+42.5% Y/Y) <font color=\"green\">beats by $4.87M</font>.</li>\n<li>Shares <font color=\"green\">+1.19%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17347775-coupa-software-reports-financial-results-third-quarter-fiscal-2019\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414071\" data-linked=\"Coupa Software beats by $0.11, beats on revenue\" data-tweet=\"$COUP - Coupa Software beats by $0.11, beats on revenue https://seekingalpha.com/news/3414071-coupa-software-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3414071-coupa-software-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414058\" data-ts=\"1543870110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414058-u-s-crude-finishesplus-4-on-trade-truce-anticipated-supply-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. crude finishes +4% on trade truce, anticipated supply cuts</a></h4><ul>\n<li>\n<a href=\"https://www.reuters.com/article/us-global-oil/oil-surges-almost-4-percent-on-trade-truce-expected-supply-cuts-idUSKBN1O201K\" target=\"_blank\">Oil prices soared</a> today after the U.S. and China agreed to a 90-day truce in their trade dispute, Canada\u2019s Alberta province <a href=\"https://seekingalpha.com/news/3413751-canada-latest-join-oil-cut-drive\" target=\"_blank\">ordered a production cut</a> to ease a glut, and OPEC <a href=\"https://seekingalpha.com/news/3413734-u-s-crude-plus-4-percent-u-s-china-trade-truce-russia-saudi-renew-opec-pact\" target=\"_blank\">looks set to reduce supply</a>: U.S. WTI settled <font color=\"green\">+4%</font> to $52.95/bbl, and Brent <font color=\"green\">+3.7%</font> to $61.69/bbl.</li>\n<li>OPEC meets on Thursday to decide production levels, and the group plus Russia is expected to announce cuts aimed at reining in a glut that has pulled down crude prices by around a third since October.</li>\n<li>\"We feel that a decline of about 1.1M-1.2M bbl/day will be required if fresh price lows are to be precluded,\" says Jim Ritterbusch, president of Ritterbusch and Associates.</li>\n<li>Among select tickers: <a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color=\"green\">+2.1%</font>, <a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color=\"green\">+1.6%</font>, <a href='https://seekingalpha.com/symbol/RDS.B' title='Royal Dutch Shell plc'>RDS.B</a> <font color=\"green\">+2.7%</font>, <a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color=\"green\">+1.8%</font>, <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color=\"green\">+4.1%</font>, <a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a> <font color=\"green\">+3.5%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color=\"green\">+4.5%</font>, <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color=\"green\">+6.1%</font>, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color=\"green\">+3.8%</font>, <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color=\"green\">+4.5%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"green\">+4.7%</font>, <a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color=\"green\">+4.4%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"green\">+4.9%</font>, <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color=\"green\">+2.4%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color=\"green\">+3.7%</font>, <a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color=\"green\">+1.4%</font>, <a href='https://seekingalpha.com/symbol/KMI' title='Kinder Morgan, Inc.'>KMI</a> <font color=\"green\">+1.3%</font>, <a href='https://seekingalpha.com/symbol/EPD' title='Enterprise Products Partners L.P'>EPD</a> <font color=\"green\">+2.7%</font>.</li>\n<li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414058\" data-linked=\"U.S. crude finishes +4% on trade truce, anticipated supply cuts\" data-tweet=\"$XOM $XOM $CVX - U.S. crude finishes +4% on trade truce, anticipated supply cuts https://seekingalpha.com/news/3414058-u-s-crude-finishesplus-4-on-trade-truce-anticipated-supply-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3414058-u-s-crude-finishesplus-4-on-trade-truce-anticipated-supply-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414057\" data-ts=\"1543869886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414057-averages-up-1-just-ahead-of-close\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Averages up more than 1% just ahead of close</a></h4><ul>\n<li>Big early gains were quickly pared back, but the averages are rallying anew in late afternoon action. Fifteen minutes ahead of the close the Dow and S&amp;P 500 are <font color=\"green\">up just over 1%</font>, and the Nasdaq <font color=\"green\">nearly 1.5%</font>.</li>\n<li>Bonds aren't buying the turnaround in market fortunes - the 10-year Treasury yield is down a fraction at 2.98%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414057\" data-linked=\"Averages up more than 1% just ahead of close\" data-tweet=\"Averages up more than 1% just ahead of close https://seekingalpha.com/news/3414057-averages-up-1-just-ahead-of-close?source=tweet\" data-url=\"https://seekingalpha.com/news/3414057-averages-up-1-just-ahead-of-close\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414053\" data-ts=\"1543869062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414053-solar-names-rise-inverters-from-china-to-be-spared-25-tariffs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar names rise as inverters from China to be spared 25% tariffs</a></h4><ul> <li>The <a href=\"https://www.pv-magazine.com/2018/12/03/inverters-from-china-to-be-spared-25-tariffs-for-at-least-90-days/\" target=\"_blank\">solar sector enjoys heady gains</a> after the U.S. and China agreed to a trade truce while they negotiate difficult issues over the next 90 days, with tariffs on $200B worth of products made in China held at 10%.</li> <li>The 90-day period could prove critical for some manufacturers such as Enphase Energy (<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color=\"green\">+6.2%</font>), which makes inverters in China and are in the process of shifting production to new locations, <em>PV Magazine</em> says; ENPH has said its contract manufacturing partner Flex will begin producing microinverters in Mexico during Q2 2019.</li> <li>Separately, First Solar (<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color=\"green\">+4.6%</font>) is <a href=\"https://thefly.com/thestreet/realmoney/index.php/FSLRid2830864/FSLR-First-Solar-upgraded-to-Neutral-from-Sell-at-Goldman-Sachs\" target=\"_blank\">upgraded</a> to Neutral from Sell with a $46 price target, raised from $39, at Goldman Sachs, which says the stock's recent weakness creates a more favorable risk/reward profile and calls FSLR's 2019 guidance a potential \"tactical catalyst\" for upward revisions to consensus estimates.</li> <li>Also: <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color=\"green\">+2.9%</font>, <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color=\"green\">+2.8%</font>, <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color=\"green\">+1.1%</font>, <a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color=\"green\">+1.4%</font>, <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color=\"green\">+1.9%</font>, <a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color=\"green\">+1.6%</font>, <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color=\"green\">+0.9%</font>, <a href='https://seekingalpha.com/symbol/YGEHY' title='YINGLI GREEN ENGY HL ADR'>OTCPK:YGEHY</a> <font color=\"green\">+36%</font>.</li> <li>ETF: <a href='https://seekingalpha.com/symbol/TAN' title='Invesco Solar Portfolio ETF'>TAN</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3414053\" data-linked=\"Solar names rise as inverters from China to be spared 25% tariffs\" data-tweet=\"$ENPH $ENPH $FSLR - Solar names rise as inverters from China to be spared 25% tariffs https://seekingalpha.com/news/3414053-solar-names-rise-inverters-from-china-to-be-spared-25-tariffs?source=tweet\" data-url=\"https://seekingalpha.com/news/3414053-solar-names-rise-inverters-from-china-to-be-spared-25-tariffs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414051\" data-ts=\"1543868310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACN\" target=\"_blank\">ACN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414051-accenture-acquires-oil-and-gas-consulting-firm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture acquires oil and gas consulting firm</a></h4><ul>\n<li>Accenture (<a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a> <font color='green'>+1.5%</font>) <a href=\"https://seekingalpha.com/pr/17347607-accenture-acquires-enaxis-consulting-provider-digital-transformation-services-oil-gas-airline\" target=\"_blank\">acquires</a> Enaxis Consulting for undisclosed terms.</li>\n<li>Enaxis Consulting is a Houston-based management consulting firm experienced in digital capabilities, data science and agile project delivery focusing on the oil and gas and oilfield services sectors and the airline industry. </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414051\" data-linked=\"Accenture acquires oil and gas consulting firm\" data-tweet=\"$ACN - Accenture acquires oil and gas consulting firm https://seekingalpha.com/news/3414051-accenture-acquires-oil-and-gas-consulting-firm?source=tweet\" data-url=\"https://seekingalpha.com/news/3414051-accenture-acquires-oil-and-gas-consulting-firm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414044\" data-ts=\"1543867224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESTC\" target=\"_blank\">ESTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414044-technology-top-5-gainers-losers-of-3_00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM</a></h4><ul>\n<li>\n<strong>Gainers: </strong>Elastic N.V. (NYSE:<a href='https://seekingalpha.com/symbol/ESTC' title='Elastic'>ESTC</a>) <font color=\"green\">+14%</font>. SITO Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a>) <font color=\"green\">+14%</font>. Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) <font color=\"green\">+10%</font>. Net Element (NASDAQ:<a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a>) <font color=\"green\">+9%</font>. Lattice Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/LSCC' title='Lattice Semiconductor Corporation'>LSCC</a>) <font color=\"green\">+8%</font>.</li> <li>\n<strong>Losers: </strong>Borqs Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/BRQS' title='Borqs Technologies, Inc'>BRQS</a>) <font color=\"red\">-28%</font>. Arlo Technologies (NYSE:<a href='https://seekingalpha.com/symbol/ARLO' title='Arlo Technologies'>ARLO</a>) <font color=\"red\">-19%</font>. UTStarcom Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/UTSI' title='UTStarcom, Inc.'>UTSI</a>) <font color=\"red\">-16%</font>. Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"red\">-14%</font>. FTE Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414044\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM\" data-tweet=\"$ESTC $ESTC $SITO - Technology - Top 5 Gainers / Losers as of 3.00 PM https://seekingalpha.com/news/3414044-technology-top-5-gainers-losers-of-3_00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3414044-technology-top-5-gainers-losers-of-3_00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414037\" data-ts=\"1543865206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414037-deal-talks-flying-in-beverage-cannabis-tobacco-realm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deal talks flying in beverage-cannabis-tobacco realm</a></h4><ul>\n<li>There's a lot of <a href=\"https://www.ft.com/content/46043990-f728-11e8-af46-2022a0b02a6c\" target=\"_blank\">discussions</a> going on between both beverage and tobacco giants with cannabis players, according to Financial Times.</li>\n<li>Following up on news from earlier today that Altria (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color='green'>+1.4%</font>) is in early talks about a takeover of Cronos Group (<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color='green'>+10.7%</font>), FT says  Coca-Cola (<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a> <font color='red'>-1.9%</font>) has held talks with Canada\u2019s Aurora Cannabis (<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color='green'>+0.5%</font>) to develop beverages and Diageo (<a href='https://seekingalpha.com/symbol/DEO' title='Diageo plc'>DEO</a> <font color='red'>-0.1%</font>) is sniffing around the sector.</li>\n<li>FT also tips that Altria has held talks with Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+0.9%</font>) and Aphria (<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a> <font color='red'>-23.4%</font>) in addition to the Cronos interest.</li>\n<li>Constellation Brands (<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a> <font color='green'>+0.4%</font>) started off the beverage-cannabis wave earlier this year when it invested just under $4B in Canopy Growth (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color='green'>+0.1%</font>).</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3413985-cronos-pops-report-altria-interest\" target=\"_blank\">Cronos pops on report of Altria interest</a> (Dec. 3)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414037\" data-linked=\"Deal talks flying in beverage-cannabis-tobacco realm\" data-tweet=\"$MO $MO $CRON - Deal talks flying in beverage-cannabis-tobacco realm https://seekingalpha.com/news/3414037-deal-talks-flying-in-beverage-cannabis-tobacco-realm?source=tweet\" data-url=\"https://seekingalpha.com/news/3414037-deal-talks-flying-in-beverage-cannabis-tobacco-realm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414036\" data-ts=\"1543865172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414036-report-vessel-arrives-chenieres-corpus-christi-lng-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Vessel arrives at Cheniere&#39;s Corpus Christi LNG plant</a></h4><ul>\n<li>A liquefied natural gas vessel, the <em>Maria Energy</em>, reportedly <a href=\"https://www.reuters.com/article/cheniere-energy-lng-corpus/vessel-arrives-at-cheniere-texas-corpus-christi-lng-export-plant-idUSL1N1Y815Y\" target=\"_blank\">arrived</a> at Cheniere Energy's (<a href='https://seekingalpha.com/symbol/LNG' title='Cheniere Energy, Inc'>LNG</a> <font color='green'>+3.3%</font>) $15B Corpus Christi LNG export facility in Texas over the weekend.</li>\n<li>The vessel is the second to visit Corpus since Cheniere started producing  LNG last month at the plant's first liquefaction train and could become the  first vessel to pick up a cargo there.</li>\n<li>It is not known why the first vessel, <em>LNG Golar Tundra</em>, visited Corpus but the company said it did not pick up LNG.</li>\n<li>The company has said it expects Corpus 1 and the fifth liquefaction  train at its Sabine Pass terminal in Louisiana to enter commercial service in Q1  2019, followed by Corpus 2 in H2 2019 and Corpus 3 in  H2 2021.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414036\" data-linked=\"Report: Vessel arrives at Cheniere&#39;s Corpus Christi LNG plant\" data-tweet=\"$LNG - Report: Vessel arrives at Cheniere&#39;s Corpus Christi LNG plant https://seekingalpha.com/news/3414036-report-vessel-arrives-chenieres-corpus-christi-lng-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3414036-report-vessel-arrives-chenieres-corpus-christi-lng-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414035\" data-ts=\"1543865031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUB\" target=\"_blank\">CUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414035-cubicminus-1-on-needham-target-trim\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cubic -1% on Needham target trim</a></h4><ul>\n<li>Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/Cubic+%28CUB%29+PT+Lowered+to+%2477+at+Needham+%26+Company/14883185.html\" target=\"_blank\">maintains</a> a Buy rating on Cubic (NYSE:<a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a>) and lowers the target from $80 to $77.</li>\n<li>Analyst James Ricchiuti cites the recent equity offering of 3.3M shares or 3.8M if over-allotment is exercised, which is expected to result in about $228M in proceeds. The firm thinks Cubic will earmark that money for debt reduction.</li>\n<li>Cubic shares are <font color=\"red\">down 1.1%</font> to $60.51.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414035\" data-linked=\"Cubic -1% on Needham target trim\" data-tweet=\"$CUB - Cubic -1% on Needham target trim https://seekingalpha.com/news/3414035-cubicminus-1-on-needham-target-trim?source=tweet\" data-url=\"https://seekingalpha.com/news/3414035-cubicminus-1-on-needham-target-trim\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414033\" data-ts=\"1543864488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPAY\" target=\"_blank\">EPAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414033-stephens-trims-bottomline-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens trims Bottomline target</a></h4><ul>\n<li>Stephens <a href=\"https://www.streetinsider.com/Analyst+Comments/Bottomline+Technologies+%28EPAY%29+PT+Lowered+to+%2464+at+Stephens/14883285.html\" target=\"_blank\">maintains</a> an Equal Weight rating on Bottomline Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/EPAY' title='Bottomline Technologies, Inc.'>EPAY</a>) but lowers the target by a dollar to $64.</li>\n<li>Analyst Brett Huff thinks Bottomline was unfairly punished with the 20% decline following the recent earnings report. The firm is incrementally interested in the long-term given the underlying stats and lack of guidance risk.</li>\n<li>EPAY shares are <font color=\"red\">down 2.4%</font> to $53.75.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414033\" data-linked=\"Stephens trims Bottomline target\" data-tweet=\"$EPAY - Stephens trims Bottomline target https://seekingalpha.com/news/3414033-stephens-trims-bottomline-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3414033-stephens-trims-bottomline-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414032\" data-ts=\"1543864144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414032-deutsche-bank-lowers-marvell-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank lowers its Marvell target</a></h4><ul>\n<li>Deutsche Bank <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Marvell+%28MRVL%29+PT+Lowered+to+%2422+at+Deutsche+Bank/14883727.html\" target=\"_blank\">maintains</a> a Buy rating on Marvell Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) but lowers its price target from $25 to $22.</li>\n<li>Marvell is among the semi names gaining today on news of a US-China trade truce. MRVL shares are <font color=\"green\">up 1.6%</font> to $16.37 today, <font color=\"red\">down 22%</font> in the past quarter, and <font color=\"red\">down 25%</font> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414032\" data-linked=\"Deutsche Bank lowers its Marvell target\" data-tweet=\"$MRVL - Deutsche Bank lowers its Marvell target https://seekingalpha.com/news/3414032-deutsche-bank-lowers-marvell-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3414032-deutsche-bank-lowers-marvell-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414027\" data-ts=\"1543864111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLEX\" target=\"_blank\">LLEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414027-lilis-energy-and-laredo-petroleum-among-energy-materials-gainers-ferrellgas-partners-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lilis Energy and Laredo Petroleum among Energy/Materials gainers; Ferrellgas Partners and Ultra Petroleum among losers</a></h4><ul> <li>\n<b>Gainers: </b>Lilis Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a>) <font color=\"green\">+15%</font>. Laredo Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/LPI' title='Laredo Petroleum Holdings, Inc.'>LPI</a>) <font color=\"green\">+14%</font>. Pacific Coast Oil Trust (NYSE:<a href='https://seekingalpha.com/symbol/ROYT' title='Pacific Coast Oil Trust'>ROYT</a>) <font color=\"green\">+14%</font>. Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a>) <font color=\"green\">+11%</font>. Crescent Point Energy (NYSE:<a href='https://seekingalpha.com/symbol/CPG' title='Crescent Point Energy Corp'>CPG</a>) <font color=\"green\">+10%</font>.</li> <li>\n<b>Losers:  </b>Ferrellgas Partners (NYSE:<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a>) <font color=\"red\">-10%</font>. Ultra Petroleum (NASDAQ:<a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a>) <font color=\"red\">-6%</font>. PBF Energy (NYSE:<a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy'>PBF</a>) <font color=\"red\">-6%</font>. HollyFrontier (NYSE:<a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corp.'>HFC</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414027\" data-linked=\"Lilis Energy and Laredo Petroleum among Energy/Materials gainers; Ferrellgas Partners and Ultra Petroleum among losers\" data-tweet=\"$LLEX $LLEX $LPI - Lilis Energy and Laredo Petroleum among Energy/Materials gainers; Ferrellgas Partners and Ultra Petroleum among losers https://seekingalpha.com/news/3414027-lilis-energy-and-laredo-petroleum-among-energy-materials-gainers-ferrellgas-partners-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3414027-lilis-energy-and-laredo-petroleum-among-energy-materials-gainers-ferrellgas-partners-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414031\" data-ts=\"1543863821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414031-mizuho-buy-micron-broadcom-on-trade-truce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho: Buy Micron, Broadcom on trade truce</a></h4><ul>\n<li>Mizuho semiconductor analyst Vijay Rakesh <a href=\"https://www.streetinsider.com/Analyst+Comments/Mizuho+Recommends+Buying+AVGO%2C+ON%2C+CY+and+MU+on+Trade+Truce/14883491.html\" target=\"_blank\">recommends</a> buying Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+3.1%</font>), ON Semiconductor (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='green'>+1.5%</font>), Cypress Semi (<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a> <font color='green'>+1.7%</font>), and Broadcom (<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='green'>+2.1%</font>) on the temporary US-China trade war truce.</li>\n<li>Rakesh: \"We are buyers of AVGO, ON, CY, and MU, which have all been disproportionately hit with tariff concerns and worries of limited 1Q19 visibility. We believe these should resolve N-T.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414031\" data-linked=\"Mizuho: Buy Micron, Broadcom on trade truce\" data-tweet=\"$MU $MU $ON - Mizuho: Buy Micron, Broadcom on trade truce https://seekingalpha.com/news/3414031-mizuho-buy-micron-broadcom-on-trade-truce?source=tweet\" data-url=\"https://seekingalpha.com/news/3414031-mizuho-buy-micron-broadcom-on-trade-truce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414030\" data-ts=\"1543863734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APLS\" target=\"_blank\">APLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414030-apellis-pharma-up-16-on-positive-aplminus-2-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apellis Pharma up 16% on positive APL-2 data</a></h4><ul> <li>Thinly traded Apellis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a> <font color=\"green\">+16.4%</font>) is up on more than 30% higher volume, albeit on turnover of only 343K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17347565-apellis-pharmaceuticals-presents-new-data-ongoing-aplminus-2-phase-2-study-patients-cold\" target=\"_blank\">announcement </a>of new data from its open-label Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03226678?spons=apellis&amp;phase=1&amp;rank=3\" target=\"_blank\">PLAUDIT </a>study evaluating complement C3 inhibitor APL-2 in patients with autoimmune hemolytic anemia &#40;AIHA&#41;, including cold agglutinin disease &#40;CAD&#41;, and warm antibody autoimmune hemolytic anemia (wAIHA). The results were presented at ASH in San Diego.</li> <li>In CAD patients receiving APL-2, average hemoglobin increased from 8.7 g/dL at baseline to 12.1 g/dL at day 56 (normal range for women is 12.0 - 15.5 g/dL, a bit higher for men). Mean absolute count of immature red blood cells called reticulocytes dropped to a level indicating sustained clinical benefit.</li> <li>In wAIHA patients, average hemoglobin increased from 9.3 g/dL at baseline to 11.3 g/dL at day 56. Mean absolute reticulocyte count dropped to a level indicating sustained clinical benefit (drop not as significant as in CAD patients).</li> <li>CAD is a rare severe autoimmune disorder in which IgM antibodies react with red blood cells below 30 degrees Celsius (86 degrees Fahrenheit), causing agglutination that leads to the destruction of red blood cells.</li> <li>Warm AIHA is a rare autoimmune disorder in which IgG antibodies react with red blood cells leading to their destruction at normal body temperature (37 degrees Celsius or 98.6 degrees Fahrenheit).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3398533-apellis-pharma-17-percent-hiccup-late-stage-study-aplminus-2\" target=\"_blank\">Apellis Pharma down 17% on hiccup in late-stage study of APL-2</a> (Oct. 18)</li> <li>#ASH18</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414030\" data-linked=\"Apellis Pharma up 16% on positive APL-2 data\" data-tweet=\"$APLS - Apellis Pharma up 16% on positive APL-2 data https://seekingalpha.com/news/3414030-apellis-pharma-up-16-on-positive-aplminus-2-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3414030-apellis-pharma-up-16-on-positive-aplminus-2-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414028\" data-ts=\"1543863673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414028-kudlow-teases-end-of-ev-subsidies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kudlow teases end of EV subsidies</a></h4><ul> <li>White House economic adviser Larry Kudlow told reporters that the White House is planning to get rid of electric car subsidies and other Obama-era auto subsidies, according to Bloomberg.</li> <li>Kudlow's statement was in response to if General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color=\"green\">+1.8%</font>) would be subject to subsidy action from the government on its own.</li> <li>The EV subsidies could be phased out as early as 2020 or 2021, noted Kudlow.</li> <li>Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color=\"green\">+2.1%</font>) has moved lower from its trading level earlier in the day after the Kudlow statement.</li> <li>Auto stocks: Nissan (<a href='https://seekingalpha.com/symbol/NSANY' title='Nissan Motor Co., Ltd. ADR'>OTCPK:NSANY</a> <font color=\"green\">+1%</font>), Ford (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color=\"green\">+2.6%</font>), Honda (<a href='https://seekingalpha.com/symbol/HMC' title='Honda Motor Co., Ltd.'>HMC</a> <font color=\"green\">+1.9%</font>), Toyota (<a href='https://seekingalpha.com/symbol/TM' title='Toyota Motor Corporation'>TM</a> <font color=\"green\">+1.6%</font>), Fiat Chrysler Automobiles (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color=\"green\">+3.7%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414028\" data-linked=\"Kudlow teases end of EV subsidies\" data-tweet=\"$GM $GM $TSLA - Kudlow teases end of EV subsidies https://seekingalpha.com/news/3414028-kudlow-teases-end-of-ev-subsidies?source=tweet\" data-url=\"https://seekingalpha.com/news/3414028-kudlow-teases-end-of-ev-subsidies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>390&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414026\" data-ts=\"1543862984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414026-fanatics-becomes-retail-partner-of-overwatch-league\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fanatics becomes retail partner of Overwatch League</a></h4><ul>   <li>Major sports licensing retailer Fanatics is making its first foray into esports merchandising, via a deal to become the <a href=\"https://seekingalpha.com/pr/17346891-overwatch-leaguetm-fanatics-team-groundbreaking-retail-licensing-ecommerce-deal\" target=\"_blank\">official retail partner</a> of the Overwatch League (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color=\"red\">-4%</font>).</li>    <li>That means an omnichannel retail experience and a significantly expanded assortment of products, according to the companies.</li>    <li>Fanatics will set up a new e-commerce/mobile shopping platform and provide on-site retail for all league events. It includes global rights to Overwatch League jerseys, fan gear, headwear and hard goods sold across all retail and wholesale channels.</li>    <li>The 2019 Overwatch League season kicks off Feb. 14.</li>    <li>ETF: <a href='https://seekingalpha.com/symbol/ESPO' title='VanEck Vectors Video Gaming and eSports ETF'>ESPO</a> <font color=\"green\">+1.3%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414026\" data-linked=\"Fanatics becomes retail partner of Overwatch League\" data-tweet=\"$ATVI $ESPO $ATVI - Fanatics becomes retail partner of Overwatch League https://seekingalpha.com/news/3414026-fanatics-becomes-retail-partner-of-overwatch-league?source=tweet\" data-url=\"https://seekingalpha.com/news/3414026-fanatics-becomes-retail-partner-of-overwatch-league\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414024\" data-ts=\"1543862400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BFFI\" target=\"_blank\">BFFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414024-ben-franklin-financialplus-4_1-after-activist-speaks-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ben Franklin Financial +4.1% after activist speaks up</a></h4><ul>\n<li>Thinly traded microcap Ben Franklin Financial (<a href='https://seekingalpha.com/symbol/BFFI' title='Ben Franklin Financial, Inc.'>OTCQB:BFFI</a>) <font color=\"green\">jum</font>ps 4.1% after Stilwell Group says it's planning to launch a proxy contest to get a seat on its board.</li>\n<li>\"The Stilwell Group believes that, due to a prolonged lack of profitability, BFFI has a duty to evaluate all strategic alternatives to maximize shareholder value,\" the activist investor says.</li>\n<li>Some 2,516 shares traded hands in early afternoon trading, more than four times its three-month average daily volume of 593.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414024\" data-linked=\"Ben Franklin Financial +4.1% after activist speaks up\" data-tweet=\"$BFFI - Ben Franklin Financial +4.1% after activist speaks up https://seekingalpha.com/news/3414024-ben-franklin-financialplus-4_1-after-activist-speaks-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3414024-ben-franklin-financialplus-4_1-after-activist-speaks-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414023\" data-ts=\"1543862239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPSNY\" target=\"_blank\">NPSNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414023-naspersplus-4-after-solid-e-commerce-gains-rise-tencent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Naspers +4% after solid e-commerce gains, rise at Tencent</a></h4><ul>   <li>Naspers ADRs (<a href='https://seekingalpha.com/symbol/NPSNY' title='Naspers Ltd. ADR'>OTCPK:NPSNY</a>) are <font color=\"green\">up 4%</font> in U.S. trading after its <a href=\"https://seekingalpha.com/news/3413739-naspers-reports-1h-results\" target=\"_blank\">first-half results</a>, and alongside a boost at affiliate Tencent (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holding Ltd. ADR'>OTCPK:TCEHY</a>), <font color=\"green\">up 4.3%</font> itself amid a temporary thaw in the U.S.-China trade war.</li>    <li>Revenues overall grew 29% in rand terms, to about $11B.</li>    <li>Meanwhile, trading profit was up 34% to $2B, and core headline earnings rose 39%.</li>    <li>The e-commerce units made strong profit contributions, CEO Bob Van Dijk said, thanks in large part to strong contributions from classifieds turning profitable, as well as from the business-to-consumer segment.</li>    <li>Internal annual rate of return on the company's flipping its Flipkart stake to Walmart (for $2.2B) was about 29%.</li>    <li>Meanwhile, plans to list its video entertainment business will unlock value as \"in future, effectively 100% of our revenues and profits will come from online businesses,\" Van Dijk says.</li>    <li>Free cash flow was a positive $271M, vs. an outflow of $96M in the same period a year ago.</li>    <li>Naspers owns 31% of Tencent.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414023\" data-linked=\"Naspers +4% after solid e-commerce gains, rise at Tencent\" data-tweet=\"$NPSNY $NPSNY $TCEHY - Naspers +4% after solid e-commerce gains, rise at Tencent https://seekingalpha.com/news/3414023-naspersplus-4-after-solid-e-commerce-gains-rise-tencent?source=tweet\" data-url=\"https://seekingalpha.com/news/3414023-naspersplus-4-after-solid-e-commerce-gains-rise-tencent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414021\" data-ts=\"1543861853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BID\" target=\"_blank\">BID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414021-sothebys-to-split-coo-position\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sotheby&#39;s to split COO position</a></h4><ul> <li>Sotheby's (<a href='https://seekingalpha.com/symbol/BID' title='Sotheby&#39;s'>BID</a> <font color='green'>+3.3%</font>) announces the appointment of John Cahill to the role of chief commercial officer and Ken Citron to the position of chief transformation officer.</li>\n<li>Cahill joins Sotheby's from his eponymous firm, Cahill Cossu Noh &amp; Robinson, while Citron recently spent five years at Christie's as COO.</li>\n<li>The companys says the two new positions assume the previous role of Sotheby's COO held by Adam Chinn, who will be leaving the company at the end of the year</li>  <li>Source: <a href=\"https://seekingalpha.com/pr/17347569-sothebys-announces-appointment-john-cahill-evp-chief-commercial-officer-and-ken-citron-evp\" target=\"_blank\">Press Release</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414021\" data-linked=\"Sotheby&#39;s to split COO position\" data-tweet=\"$BID - Sotheby&#39;s to split COO position https://seekingalpha.com/news/3414021-sothebys-to-split-coo-position?source=tweet\" data-url=\"https://seekingalpha.com/news/3414021-sothebys-to-split-coo-position\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414019\" data-ts=\"1543861363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414019-karyopharm-up-5-on-selinexor-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Karyopharm up 5% on selinexor data</a></h4><ul> <li>Karyopharm Therapeutics (<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color=\"green\">+4.8%</font>) is up on 50% higher volume on the heels of <a href=\"https://seekingalpha.com/pr/17347411-karyopharm-reports-updated-selinexor-data-phase-2b-storm-phase-1b-2-stomp-studies-relapsed\" target=\"_blank\">updated dat</a>a on selinexor in multiple myeloma &#40;MM&#41;. The results were presented at ASH in San Diego.</li> <li>In the Phase 1b/2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02336815?titles=storm&amp;spons=karyopharm&amp;rank=1\" target=\"_blank\">STORM </a>study evaluating selinexor + dexamethasone, combined with standard-of-care treatment with Pomalyst (pomalidomide) or Darzalex (daratumumab), in heavily pretreated MM patients, the overall response response rate &#40;ORR&#41; was 26.2% (n=32/122), including two complete responders, both minimal residual disease-negative (less likely to relapse). The disease control rate (responders + stable cancer) was 78.7% (n=96/122). Median overall survival &#40;OS&#41; was 8.6 months.</li> <li>In the Phase 1b/2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02343042?titles=stomp&amp;spons=karyopharm&amp;rank=1\" target=\"_blank\">STOMP </a>study, the arm evaluating selinexor, combined with Darzalex and low-dose dexamethasone, in treatment-resistant MM patients who had received at least three prior lines of therapy, showed an ORR of 73% (n=19/26), all partial responders (seven very good partials). In the arm assessing selinexor + Pomalyst + dexamethasone, the ORR was 50% (n=17/34).</li> <li>The company's U.S. marketing application seeking approval for selinexor + low-dose dexamethasone in penta-refractory MM is currently under FDA review with an action date of April 6, 2019.</li> <li>#ASH18</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414019\" data-linked=\"Karyopharm up 5% on selinexor data\" data-tweet=\"$KPTI - Karyopharm up 5% on selinexor data https://seekingalpha.com/news/3414019-karyopharm-up-5-on-selinexor-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3414019-karyopharm-up-5-on-selinexor-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414013\" data-ts=\"1543860625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLKPF\" target=\"_blank\">VLKPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414013-volkswagen-u-s-sales-down-8-in-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volkswagen U.S. sales down 8% in November</a></h4><ul>\n<li>Volkswagen (<a href='https://seekingalpha.com/symbol/VLKPF' title='Volkswagen AG Pfd Shares'>OTC:VLKPF</a>) unit sales <a href=\"https://media.vw.com/en-us/releases/1107\" sasource=\"qp_sum_news_9\" target=\"_blank\">-8%</a> to 26,789 units vs. a -2.5% forecast from Edmunds.</li>\n<li>Golf sales fell 42% to 2,488 units.</li>\n<li>Jetta sales up 10% to 9,207 units.</li>\n<li>Passat sales squeezed 31% to 2,156 units.</li>\n<li>2018 Tiguan sales rose 30% to 6,794 units.</li>\n<li>Atlas sales grew 2% to 5,233 units.</li>\n<li>CPO sales increased 18% to 7,533 units</li>\n<li>YTD Volkswagen U.S. sales +4% to 322,017 units.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414013\" data-linked=\"Volkswagen U.S. sales down 8% in November\" data-tweet=\"$VLKPF $VWAGY $VLKAF - Volkswagen U.S. sales down 8% in November https://seekingalpha.com/news/3414013-volkswagen-u-s-sales-down-8-in-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3414013-volkswagen-u-s-sales-down-8-in-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414012\" data-ts=\"1543860611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STXB\" target=\"_blank\">STXB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414012-spirit-of-texas-bancshares-leads-financial-gainers-pagseguro-digital-and-hexindai-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit of Texas Bancshares leads financial gainers; PagSeguro Digital and Hexindai among losers</a></h4><ul> <li>\n<b>Gainers:</b> Spirit of Texas Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/STXB' title='Spirit of Texas Bancshares'>STXB</a>) <font color=\"green\">+7%</font>. PennyMac Financial Services (NYSE:<a href='https://seekingalpha.com/symbol/PFSI' title='PennyMac Financial Services'>PFSI</a>) <font color=\"green\">+7%</font>. Safeguard Scientifics (NYSE:<a href='https://seekingalpha.com/symbol/SFE' title='Safeguard Scientifics, Inc.'>SFE</a>) <font color=\"green\">+6%</font>. X Financial (NYSE:<a href='https://seekingalpha.com/symbol/XYF' title='X Financial'>XYF</a>) <font color=\"green\">+6%</font>. China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers:</b> BGC Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/BGCP' title='BGC Partners, Inc.'>BGCP</a>) <font color=\"red\">-35%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"red\">-26%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414012\" data-linked=\"Spirit of Texas Bancshares leads financial gainers; PagSeguro Digital and Hexindai among losers\" data-tweet=\"$STXB $STXB $PFSI - Spirit of Texas Bancshares leads financial gainers; PagSeguro Digital and Hexindai among losers https://seekingalpha.com/news/3414012-spirit-of-texas-bancshares-leads-financial-gainers-pagseguro-digital-and-hexindai-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3414012-spirit-of-texas-bancshares-leads-financial-gainers-pagseguro-digital-and-hexindai-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414008\" data-ts=\"1543859917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBRL\" target=\"_blank\">CBRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414008-cracker-barrel-short-pick-tilson-conference\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cracker Barrel a short pick at Tilson conference</a></h4><ul><li>Cracker Barrel Old Country Store (<a href='https://seekingalpha.com/symbol/CBRL' title='Cracker Barrel Old Country Store, Inc.'>CBRL</a> <font color='red'>-1.1%</font>) trades lower after the restaurant stock is mentioned as a short idea by Pinnacle View Capital at the Whitney Tilson short conference.</li></ul><div class=\"tiny-share-widget\" data-id=\"3414008\" data-linked=\"Cracker Barrel a short pick at Tilson conference\" data-tweet=\"$CBRL - Cracker Barrel a short pick at Tilson conference https://seekingalpha.com/news/3414008-cracker-barrel-short-pick-tilson-conference?source=tweet\" data-url=\"https://seekingalpha.com/news/3414008-cracker-barrel-short-pick-tilson-conference\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414001\" data-ts=\"1543859619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414001-global-bloods-voxelotor-shows-positive-action-in-late-stage-sickle-cell-study-shares-up-56\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Blood&#39;s voxelotor shows positive action in late-stage sickle cell study; shares up 56%</a></h4><ul>\n<li>Global Blood Therapeutics (<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color=\"green\">+55.7%</font>) is up on more than an 8x surge in volume on the heels of <a href=\"https://seekingalpha.com/pr/17347322-gbt-announces-positive-24-week-results-phase-3-hope-study-demonstrating-clinically\" target=\"_blank\">positive data</a> from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03036813?titles=hope&amp;spons=global+blood+therapeutics&amp;phase=2&amp;rank=1\" target=\"_blank\">HOPE</a>, evaluating voxelotor in patients at least 12 years old with sickle cell disease &#40;SCD&#41;. The results were presented at ASH in San Diego.</li>\n<li>The study met the primary endpoint of at least a 1 g/dL increase in hemoglobin from baseline to week 24 compared to placebo. Specifically, 65% of patients receiving 1500 mg of voxelotor and 33% of those receiving 900 mg achieved at least a 1 g/dL increase in hemoglobin versus 10% for placebo. The separation from control was statistically significant for both doses.</li>\n<li>Patients receiving 1500 mg showed an average hemoglobin level of 10 g/dL at week 24 from a baseline of 8.6 g/dL, a clinically meaningful improvement in anemia.</li>\n<li>The study is ongoing with an estimated completion date of June 2019.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3413859-fda-accepts-gbts-proposal-accelerated-approval-pathway-voxelotor-shares-42-percent-premarket\" target=\"_blank\">FDA accepts GBT's proposal for accelerated approval pathway for Voxelotor; shares up 42% premarket</a> (Dec. 3)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3366490-global-blood-minus-7-percent-despite-positive-data-sickle-cell-drug-trial\" target=\"_blank\">Global Blood -7% despite positive data from sickle cell drug trial</a> (June 27)</li>\n<li>#ASH18</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3414001\" data-linked=\"Global Blood&#39;s voxelotor shows positive action in late-stage sickle cell study; shares up 56%\" data-tweet=\"$GBT - Global Blood&#39;s voxelotor shows positive action in late-stage sickle cell study; shares up 56% https://seekingalpha.com/news/3414001-global-bloods-voxelotor-shows-positive-action-in-late-stage-sickle-cell-study-shares-up-56?source=tweet\" data-url=\"https://seekingalpha.com/news/3414001-global-bloods-voxelotor-shows-positive-action-in-late-stage-sickle-cell-study-shares-up-56\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414004\" data-ts=\"1543859209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414004-nielsen-jumps-on-report-new-ceo-proceeds-sale-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen jumps on report that new CEO proceeds with sale talks</a></h4><ul>   <li>Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a>) is <font color=\"green\">up 3.2%</font> and tagged a session high after The Deal says a new CEO isn't crimping sale explorations for the company.</li>    <li>New chief David Kenny takes over today, and the report notes that gives potential private-equity suitors a central point of contact.</li>    <li>Madison Dearborn is reportedly looking at a bid, and at least six other firms have hired advisers, according to the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414004\" data-linked=\"Nielsen jumps on report that new CEO proceeds with sale talks\" data-tweet=\"$NLSN - Nielsen jumps on report that new CEO proceeds with sale talks https://seekingalpha.com/news/3414004-nielsen-jumps-on-report-new-ceo-proceeds-sale-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3414004-nielsen-jumps-on-report-new-ceo-proceeds-sale-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414003\" data-ts=\"1543859175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414003-healthcare-and-industrial-goods-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare and Industrial goods dominate midday movers</a></h4><ul> <li>\n<strong>Gainers: </strong>Tesaro (NASDAQ:<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a>) <font color=\"green\">+58%</font>. Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a>) <font color=\"green\">+55%</font>. Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a>) <font color=\"green\">+43%</font>. Hudson Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies, Inc.'>HDSN</a>) <font color=\"green\">+40%</font>. NRC Group Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/NRCG' title='NRC Group Holdings Corp'>NRCG</a>) <font color=\"green\">+21%</font>. Vanda Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a>) <font color=\"green\">+18%</font>. Biohaven Pharmaceutical Holding (NYSE:<a href='https://seekingalpha.com/symbol/BHVN' title='Biohaven Pharmaceutical Holding Company Ltd.'>BHVN</a>) <font color=\"green\">+17%</font>. Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) <font color=\"green\">+16%</font>. Osmotica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/OSMT' title='Osmotica Pharmaceuticals plc'>OSMT</a>) <font color=\"green\">+15%</font>. Lilis Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a>) <font color=\"green\">+15%</font>.</li> <li>\n<strong>Losers: </strong>Sharing Economy International (<a href='https://seekingalpha.com/symbol/SEII' title='Sharing Economy International Inc.'>OTC:SEII</a>) <font color=\"red\">-48%</font>. Sienna Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNNA' title='Sienna Biopharmaceuticals'>SNNA</a>) <font color=\"red\">-37%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"red\">-25%</font>. Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-23%</font>. Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-22%</font>. Tel-Instrument Electronics (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIK' title='Tel-Instrument Electronics Corp'>TIK</a>) <font color=\"red\">-19%</font>. Cass Information Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASS' title='Cass Information Systems, Inc'>CASS</a>) <font color=\"red\">-19%</font>. Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"red\">-19%</font>. UTStarcom Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/UTSI' title='UTStarcom, Inc.'>UTSI</a>) <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414003\" data-linked=\"Healthcare and Industrial goods dominate midday movers\" data-tweet=\"$TSRO $TSRO $GBT - Healthcare and Industrial goods dominate midday movers https://seekingalpha.com/news/3414003-healthcare-and-industrial-goods-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3414003-healthcare-and-industrial-goods-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413996\" data-ts=\"1543858917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413996-health-insurance-innovations-down-3-on-mention-short-seller-muddy-waters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Insurance Innovations down 3% on mention by short seller Muddy Waters</a></h4><ul> <li>Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a> <font color=\"red\">-3.3%</font>) is under modest pressure in apparent reaction to a mention by short seller Carson Block, also known as Muddy Waters, at the Whitney Tilson Short Conference.</li> <li>He also has Insys Therapeutics (<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a>) on his radar.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3413971-carson-blocks-short-ideas-kase-conference\" target=\"_blank\">Carson Block's short ideas at Kase conference</a> (Dec. 3)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413996\" data-linked=\"Health Insurance Innovations down 3% on mention by short seller Muddy Waters\" data-tweet=\"$HIIQ $HIIQ $INSYQ - Health Insurance Innovations down 3% on mention by short seller Muddy Waters https://seekingalpha.com/news/3413996-health-insurance-innovations-down-3-on-mention-short-seller-muddy-waters?source=tweet\" data-url=\"https://seekingalpha.com/news/3413996-health-insurance-innovations-down-3-on-mention-short-seller-muddy-waters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3414000\" data-ts=\"1543858808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVE\" target=\"_blank\">CVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3414000-canadian-crude-surges-after-alberta-orders-production-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian crude surges after Alberta orders production cuts</a></h4><ul> <li>\n<a href=\"https://www.reuters.com/article/us-canada-alberta-crude/canadian-crude-prices-rally-after-alberta-orders-output-cuts-idUSKBN1O2212\" target=\"_blank\">Canadian oil prices rally</a> to four-month highs after Alberta said it would mandate production cuts that some producers had requested after pipeline bottlenecks forced their oil to be sold at severe discounts.</li> <li>Western Canada Select traded at a discount of $19.50/bbl below U.S. crude futures, Reuters reports, the smallest discount since July 18; WCS traded at a ~$28.75/bbl discount on Friday.</li> <li>Alberta <a href=\"https://seekingalpha.com/news/3413870-alberta-orders-oil-producers-cut-production-face-price-crisis\" target=\"_blank\">announced Sunday</a> that oil producers must collectively cut output by 325K bbl/day, or 8.7%, starting in January to ease rising inventories and pipeline bottlenecks.</li> <li>Relevant shares are mostly higher, with Cenovus Energy (<a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color=\"green\">+9.9%</font>) and Canadian Natural Resources (<a href='https://seekingalpha.com/symbol/CNQ' title='Canadian Natural Resources, Ltd.'>CNQ</a> <font color=\"green\">+8.8%</font>), which have favored a move, up sharply, but Suncor Energy (<a href='https://seekingalpha.com/symbol/SU' title='Suncor Energy Inc.'>SU</a> <font color=\"red\">-0.7%</font>) and Imperial Oil (<a href='https://seekingalpha.com/symbol/IMO' title='Imperial Oil Ltd'>IMO</a> <font color=\"red\">-3.6%</font>), which also own refineries and have little enthusiasm for such government intervention, are lower.</li> <li>Also: <a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color=\"green\">+2.3%</font>, <a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a> <font color=\"green\">+4.7%</font>, <a href='https://seekingalpha.com/symbol/TRP' title='TransCanada Corporation'>TRP</a> <font color=\"green\">+2%</font>, <a href='https://seekingalpha.com/symbol/CPG' title='Crescent Point Energy Corp'>CPG</a> <font color=\"green\">+9.1%</font>, <a href='https://seekingalpha.com/symbol/BTE' title='Baytex Energy Corp.'>BTE</a> <font color=\"green\">+10.8%</font>, <a href='https://seekingalpha.com/symbol/ERF' title='Enerplus Corporation'>ERF</a> <font color=\"green\">+3.5%</font>, <a href='https://seekingalpha.com/symbol/HUSKF' title='Husky Energy Inc.'>OTCPK:HUSKF</a> <font color=\"green\">+0.5%</font>, <a href='https://seekingalpha.com/symbol/MEGEF' title='Meg Energy Corp.'>OTCPK:MEGEF</a> <font color=\"red\">-1.8%</font>, <a href='https://seekingalpha.com/symbol/ATHOF' title='Athabasca Oil Corp.'>OTCPK:ATHOF</a> <font color=\"green\">+14.9%</font>, <a href='https://seekingalpha.com/symbol/SPGYF' title='Whitecap Resources, Inc.'>OTCPK:SPGYF</a> <font color=\"green\">+5.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3414000\" data-linked=\"Canadian crude surges after Alberta orders production cuts\" data-tweet=\"$CVE $CVE $CNQ - Canadian crude surges after Alberta orders production cuts https://seekingalpha.com/news/3414000-canadian-crude-surges-after-alberta-orders-production-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3414000-canadian-crude-surges-after-alberta-orders-production-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413999\" data-ts=\"1543858744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413999-reliance-team-up-paying-off-in-india-for-facebook-via-whatsapp-phones\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reliance team-up paying off in India for Facebook via &#39;WhatsApp phones&#39;</a></h4><ul>     <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+2%</font>) is pursuing a strategy with upstart India wireless provider Reliance Jio to tap fast growth in the world's fastest-growing major Internet market, via inexpensive phones that have come to be known in rural areas as \"<a href=\"https://www.bloombergquint.com/business/how-facebook-uses-whatsapp-phones-to-tap-next-emerging-market#gs.XdApwrk\" target=\"_blank\">WhatsApp phones</a>.\"</li>    <li>India has 480M Internet users (75% more than the U.S., and second only to China) but is expected to grow to 737M users by 2022, Forrester Research says.</li>    <li>Reliance Jio is capturing heavy growth through inexpensive phones and plans focused on messaging, and it and WhatsApp are likely to benefit from building a user base that will move on from messaging to e-commerce, payments and food delivery, among many other services.</li>    <li>India is already WhatsApp's biggest market, with more than 200M users. A pairing with Reliance's Mukesh Ambani (India's richest man) is paying benefits as Reliance Jio jumped on the scene with the country's most advanced wireless network and drew millions into the digital age almost overnight.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413999\" data-linked=\"Reliance team-up paying off in India for Facebook via &#39;WhatsApp phones&#39;\" data-tweet=\"$FB - Reliance team-up paying off in India for Facebook via &#39;WhatsApp phones&#39; https://seekingalpha.com/news/3413999-reliance-team-up-paying-off-in-india-for-facebook-via-whatsapp-phones?source=tweet\" data-url=\"https://seekingalpha.com/news/3413999-reliance-team-up-paying-off-in-india-for-facebook-via-whatsapp-phones\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413995\" data-ts=\"1543858426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413995-tech-lunch-trade-truce-drives-tech-recovery\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech lunch: Trade truce drives tech recovery</a></h4><ul> <li>The tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) <font color=\"green\">gains 1.5%</font> on the 90-day truce in the US-China trade war with Chinese internet stocks, semiconductors, and hardware names among the top gainers.</li> <li>The S&amp;P 500 IT index and Nasdaq 100 are <font color=\"green\">up 1.4%</font> while the Philadelphia Semiconductor Index <font color=\"green\">gains 2.3%</font>.</li> <li>Related China tech ETFs: <a href='https://seekingalpha.com/symbol/KWEB' title='KraneShares CSI China Internet ETF'>KWEB</a>, <a href='https://seekingalpha.com/symbol/CQQQ' title='Invesco China Technology ETF'>CQQQ</a>, <a href='https://seekingalpha.com/symbol/QQQC-OLD' title='Global X China Technology ETF'>QQQC-OLD</a>, <a href='https://seekingalpha.com/symbol/CWEB' title='Direxion Daily CSI China Internet Index Bull 2x Shares ETF'>CWEB</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3413995\" data-linked=\"Tech lunch: Trade truce drives tech recovery\" data-tweet=\"$XLK $KWEB $CQQQ - Tech lunch: Trade truce drives tech recovery https://seekingalpha.com/news/3413995-tech-lunch-trade-truce-drives-tech-recovery?source=tweet\" data-url=\"https://seekingalpha.com/news/3413995-tech-lunch-trade-truce-drives-tech-recovery\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413993\" data-ts=\"1543858216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413993-incytes-jakafi-successful-in-mid-stage-gvhd-study-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Incyte&#39;s Jakafi successful in mid-stage GvHD study; shares up 7%</a></h4><ul> <li>A Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02953678?titles=reach1&amp;spons=incyte&amp;phase=1&amp;rank=1\" target=\"_blank\">REACH1</a>, evaluating Incyte's (<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color=\"green\">+6.5%</font>) Jakafi (ruxolitinib), combined with corticosteroids, in patients with acute graft-versus-host disease (GvHD) who failed to respond adequately to corticosteroids <a href=\"https://seekingalpha.com/pr/17347291-results-reach1-study-ruxolitinib-jakafi-treatment-acute-graft-versus-host-disease-demonstrate\" target=\"_blank\">met the primary endpoint</a>. The results were presented at ASH in San Diego.</li> <li>Specifically, treated patients showed an overall response rate &#40;ORR&#41; of 55% (n=39/71) at day 28. 73% (n=52/71) experienced a response at some point in the study. 68% (n=48/71) had serious or life-threatening GvHD at baseline.</li> <li>The median duration of response in day 28 responders who were followed for at least six months was 345 days.</li> <li>The company's U.S. marketing application is currently under FDA review with an action date of February 24, 2019.</li>\n<li>The FDA approved Jakafi for myelofibrosis is 2011 and for polycythemia vera in 2014.</li> <li>#ASH18</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413993\" data-linked=\"Incyte&#39;s Jakafi successful in mid-stage GvHD study; shares up 7%\" data-tweet=\"$INCY - Incyte&#39;s Jakafi successful in mid-stage GvHD study; shares up 7% https://seekingalpha.com/news/3413993-incytes-jakafi-successful-in-mid-stage-gvhd-study-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3413993-incytes-jakafi-successful-in-mid-stage-gvhd-study-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413992\" data-ts=\"1543857333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQM\" target=\"_blank\">SQM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413992-tianqi-buys-sqm-stake-from-nutrien-for-4_06b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tianqi buys SQM stake from Nutrien for $4.06B</a></h4><ul>\n<li>China\u2019s Tianqi Lithium has <a href=\"https://www.reuters.com/article/us-chile-tianqi-lithium/nutrien-to-auction-stake-in-lithium-miner-sqm-for-over-4-billion-idUSKBN1O217F\" target=\"_blank\">purchased a 23.77% stake</a> in lithium miner Sociedad Quimica y Minera de Chile (<a href='https://seekingalpha.com/symbol/SQM' title='Chemical & Mining Co. of Chile Inc.'>SQM</a> <font color='green'>+5.5%</font>) from Nutrien (<a href='https://seekingalpha.com/symbol/NTR' title='Nutrien Ltd.'>NTR</a> <font color='green'>+0.1%</font>) for $4.066B as planned, the Chilean stock exchange reports.</li>\n<li>Tianqi struck the deal earlier this year to buy the stake from NTR, the company formed by the merger of Agrium and Potash Corp. of Saskatchewan, which NTR was required to sell as part of the deal, which quickly was met with scrutiny from regulators, competitors and consumer groups.</li>\n<li>NTR says it plans to use proceeds from selling stakes in SQM and two other companies to expand its network of farm retail stores in the U.S. and establish one in Brazil.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413992\" data-linked=\"Tianqi buys SQM stake from Nutrien for $4.06B\" data-tweet=\"$SQM $SQM $NTR - Tianqi buys SQM stake from Nutrien for $4.06B https://seekingalpha.com/news/3413992-tianqi-buys-sqm-stake-from-nutrien-for-4_06b?source=tweet\" data-url=\"https://seekingalpha.com/news/3413992-tianqi-buys-sqm-stake-from-nutrien-for-4_06b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413987\" data-ts=\"1543856758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHVN\" target=\"_blank\">BHVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413987-biohaven-pharma-up-17-on-positive-data-on-zydis-in-migraine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biohaven Pharma up 17% on positive data on Zydis in migraine</a></h4><ul> <li>Thinly traded Biohaven Pharmaceutical Holding Company (<a href='https://seekingalpha.com/symbol/BHVN' title='Biohaven Pharmaceutical Holding Company Ltd.'>BHVN</a> <font color=\"green\">+17.1%</font>) is up on more than double normal volume following its <a href=\"https://seekingalpha.com/pr/17346577-biohaven-delivers-positive-phase-3-results-rimegepant-zydis-orally-dissolving-tablet-odt\" target=\"_blank\">announcement </a>of topline data from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03461757?spons=biohaven&amp;phase=12&amp;rank=7\" target=\"_blank\">BHV3000-303</a>, evaluating lead candidate Zydis orally dissolving tablet formulation of rimegepant for the acute treatment of migraine.</li> <li>The study met the two co-primary endpoints of pain freedom and freedom from the most bothersome symptom at hour 2 with a single dose. The treatment effect was experienced in as little as 15 minutes and the separation from placebo was statistically significant at 60 minutes.</li> <li>Specifically, 21.2% of patients receiving Zydis experienced pain freedom at hour 2 compared to 10.9% for placebo (p&lt;0.0001). 35.1% experienced pain from the most bothersome symptom at hour 2 versus 26.8% for control (p=0.0009).</li> <li>A range of secondary endpoints was achieved as well.</li> <li>The company plans to file its U.S. marketing application in 2019.</li> <li>Migraine-related tickers: <a href='https://seekingalpha.com/symbol/IGXT' title='IntelGenx Technologies Corp.'>OTCQX:IGXT</a>, <a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>, <a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>, <a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>, <a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>, <a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>, <a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a>, <a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3413987\" data-linked=\"Biohaven Pharma up 17% on positive data on Zydis in migraine\" data-tweet=\"$BHVN $BHVN $IGXT - Biohaven Pharma up 17% on positive data on Zydis in migraine https://seekingalpha.com/news/3413987-biohaven-pharma-up-17-on-positive-data-on-zydis-in-migraine?source=tweet\" data-url=\"https://seekingalpha.com/news/3413987-biohaven-pharma-up-17-on-positive-data-on-zydis-in-migraine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413986\" data-ts=\"1543856724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413986-new-age-beverages-leads-consumer-gainers-orchids-paper-products-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages leads consumer gainers; Orchids Paper Products among losers</a></h4><ul> <li>\n<b>Gainers: </b>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"green\">+11%. </font>G-III Apparel Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a>) <font color=\"green\">+9%</font>. LifeVantage (NASDAQ:<a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a>) <font color=\"green\">+6%</font>. SORL Auto Parts (NASDAQ:<a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a>) <font color=\"green\">+6%</font>. Forward Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a>) <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers: </b> Ballantyne Strong (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTN' title='Ballantyne Strong, Inc.'>BTN</a>) <font color=\"red\">-14%</font>. Xcel Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a>) <font color=\"red\">-12%</font>. Orchids Paper Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a>) <font color=\"red\">-8%</font>. Electrameccanica Vehicles (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLO' title='Electrameccanica Vehicles Corp. Ltd.'>SOLO</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413986\" data-linked=\"New Age Beverages leads consumer gainers; Orchids Paper Products among losers\" data-tweet=\"$NBEV $NBEV $GIII - New Age Beverages leads consumer gainers; Orchids Paper Products among losers https://seekingalpha.com/news/3413986-new-age-beverages-leads-consumer-gainers-orchids-paper-products-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3413986-new-age-beverages-leads-consumer-gainers-orchids-paper-products-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413985\" data-ts=\"1543856570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRON\" target=\"_blank\">CRON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413985-cronos-pops-on-report-of-altria-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cronos pops on report of Altria interest</a></h4><ul> <li>Cronos (<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color=\"green\">+12.9%</font>) skyrocktets after Reuters reports that Altria (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color=\"green\">+1.2%</font>) is in early talks to acquire the company.</li> <li>The story is developing. Details will be added to the post.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413985\" data-linked=\"Cronos pops on report of Altria interest\" data-tweet=\"$CRON $CRON $MO - Cronos pops on report of Altria interest https://seekingalpha.com/news/3413985-cronos-pops-on-report-of-altria-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3413985-cronos-pops-on-report-of-altria-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>101&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413983\" data-ts=\"1543856361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHA\" target=\"_blank\">APHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413983-select-marijuana-stocks-follow-aphria-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select marijuana stocks follow Aphria lower</a></h4><ul>\n<li>Select marijuana stocks are jittery following the biting short recommendation today on Aphria (<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a> <font color='red'>-18.6%</font>) by Quintessential Capital\u2019s Gabriel Grego.</li>\n<li>While Aphria is calling the accusations of fraud both false and defamatory, shares sunk to a 52-week low of $5.61 earlier.</li>\n<li>Trading lower amid the development are Hexo (HYYDF <font color='red'>-4.8%</font>), Harvest One Cannabis (<a href='https://seekingalpha.com/symbol/HRVOF' title='Harvest One Cannabis Inc.'>OTCPK:HRVOF</a> <font color='red'>-8.4%</font>) and Organigram (<a href='https://seekingalpha.com/symbol/OGRMF' title='Organigram Holdings, Inc.'>OTCQX:OGRMF</a> <font color='red'>-4.9%</font>).</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3413834-aphria-minus-15-percent-short-pitch-kase-conference\" target=\"_blank\">Aphria -15% on short pitch at Kase conference</a> (Dec. 3)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413983\" data-linked=\"Select marijuana stocks follow Aphria lower\" data-tweet=\"$APHA $APHA $HEXO - Select marijuana stocks follow Aphria lower https://seekingalpha.com/news/3413983-select-marijuana-stocks-follow-aphria-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3413983-select-marijuana-stocks-follow-aphria-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413973\" data-ts=\"1543855614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRGDF\" target=\"_blank\">DRGDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413973-iss-sides-detour-gold-board-proposals-in-paulson-proxy-fight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ISS sides with Detour Gold board proposals in Paulson proxy fight</a></h4><ul> <li>John Paulson's effort to replace most of Detour Gold's (<a href='https://seekingalpha.com/symbol/DRGDF' title='Detour Gold Corp.'>OTCPK:DRGDF</a> <font color=\"green\">+3.4%</font>) board  was dealt a blow after proxy advisory firm Institutional Shareholder Services urges investors to <a href=\"https://business.financialpost.com/commodities/mining/paulson-rebuffed-from-stocking-detour-board-by-iss\" target=\"_blank\">side with the company's plans</a> to appoint just two of the  activist investor's eight nominees.</li> <li>ISS says while Paulson made a  case that change was warranted at Detour, the mining company had been  responsive to its concerns by appointing three new directors in August  and <a href=\"https://seekingalpha.com/news/3410132-detour-gold-agrees-add-two-paulson-board-nominees\" target=\"_blank\">offering to appoint</a> two of Paulson's nominees to the board.</li> <li>Paulson, which owns a 5.7% stake in Detour, also has called for Detour\u2019s interim CEO and Chairman Michael Kenyon to resign, but ISS says appointing a temporary replacement for Kenyon now could delay the search for a permanent CEO.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413973\" data-linked=\"ISS sides with Detour Gold board proposals in Paulson proxy fight\" data-tweet=\"$DRGDF - ISS sides with Detour Gold board proposals in Paulson proxy fight https://seekingalpha.com/news/3413973-iss-sides-detour-gold-board-proposals-in-paulson-proxy-fight?source=tweet\" data-url=\"https://seekingalpha.com/news/3413973-iss-sides-detour-gold-board-proposals-in-paulson-proxy-fight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413970\" data-ts=\"1543855107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413970-new-age-beverages-deal-called-transformative\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages deal called &#39;transformative&#39;</a></h4><ul>\n<li>Roth capital analyst David Bain calls the acquisition by New Age Beverages (<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+7.3%</font>) of Morinda Holdings a \"transformative\" deal that gives the company a global distribution network for weed products.</li>\n<li>Bains thinks New Age Beverages is close to a new cannabis partnership (per Bloomberg).</li>\n<li>New Age execs have a conference call scheduled for tomorrow at 8:30 a.m. ET.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3413768-new-age-beverages-announces-merger-morinda-inc-85m-shares-19-percent-premarket\" target=\"_blank\">New Age Beverages announces merger with Morinda, Inc. for $85M, shares up 19% premarket</a> (Dec. 3)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413970\" data-linked=\"New Age Beverages deal called &#39;transformative&#39;\" data-tweet=\"$NBEV - New Age Beverages deal called &#39;transformative&#39; https://seekingalpha.com/news/3413970-new-age-beverages-deal-called-transformative?source=tweet\" data-url=\"https://seekingalpha.com/news/3413970-new-age-beverages-deal-called-transformative\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413966\" data-ts=\"1543854516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZUL\" target=\"_blank\">AZUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413966-azulminus-4-after-goldman-sachs-pulls-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Azul -4% after Goldman Sachs pulls back</a></h4><ul>\n<li>Azul (<a href='https://seekingalpha.com/symbol/AZUL' title='Azul'>AZUL</a> <font color='red'>-4.1%</font>) trades lower after Goldman Sachs lowers its rating to Neutral from Buy.</li>\n<li>The firm thinks the market is already pricing in Azul's expected margin gains for 2019 off lower oil prices. Shares of Azul are up 61% over the last 90 days on investor confidence over the carrier's building momentum.</li>\n<li>\"We believe the risk/reward is no longer as attractive at this point,\" sums up the Goldman analyst team in today's note.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413966\" data-linked=\"Azul -4% after Goldman Sachs pulls back\" data-tweet=\"$AZUL - Azul -4% after Goldman Sachs pulls back https://seekingalpha.com/news/3413966-azulminus-4-after-goldman-sachs-pulls-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3413966-azulminus-4-after-goldman-sachs-pulls-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413964\" data-ts=\"1543854104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRSN\" target=\"_blank\">VRSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413964-verisignplus-2-on-ftc-antitrust-clearance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VeriSign +2% on FTC antitrust clearance</a></h4><ul>\n<li>The Federal Trade Commission <a href=\"https://www.ftc.gov/enforcement/premerger-notification-program/early-termination-notices/20190212\" target=\"_blank\">grants</a> antitrust clearance for VeriSign's (NASDAQ:<a href='https://seekingalpha.com/symbol/VRSN' title='VeriSign, Inc.'>VRSN</a>) sale of certain Security Services assets to NeuStar, which is owned by Golden Gate Capital.</li>\n<li>The deal, first <a href=\"https://seekingalpha.com/pr/17312829-verisign-reports-third-quarter-2018-results\" target=\"_blank\">announced</a> in October, includes a $50M payment at closing plus a contingent amount a year later with a $120M cap.</li>\n<li>VeriSign shares are <font color=\"green\">up 2%</font> to $159.39.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413964\" data-linked=\"VeriSign +2% on FTC antitrust clearance\" data-tweet=\"$VRSN - VeriSign +2% on FTC antitrust clearance https://seekingalpha.com/news/3413964-verisignplus-2-on-ftc-antitrust-clearance?source=tweet\" data-url=\"https://seekingalpha.com/news/3413964-verisignplus-2-on-ftc-antitrust-clearance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413962\" data-ts=\"1543853981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRY\" target=\"_blank\">TLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413962-tilray-pitched-short-kase-conference\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilray pitched as short at Kase conference</a></h4><ul>\n<li>Presenting at the Kase Learning Short-Selling Conference, Aristides Capital's Chris Brown pitches Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>).</li>\n<li>Legalization doesn't mean a massive shift where everyone suddenly begins toking up, says Brown. He instead sees the marijuana market doubling every three-five years.</li>\n<li>Tilray is pretty pricey on an enterprise value-to-sales metric, says Brown - not good for future returns.</li>\n<li>Shares are <font color=\"red\">down 2.7%</font>.</li>\n<li>#KaseLearning</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413962\" data-linked=\"Tilray pitched as short at Kase conference\" data-tweet=\"$TLRY - Tilray pitched as short at Kase conference https://seekingalpha.com/news/3413962-tilray-pitched-short-kase-conference?source=tweet\" data-url=\"https://seekingalpha.com/news/3413962-tilray-pitched-short-kase-conference\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413958\" data-ts=\"1543853576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413958-stocks-pare-big-early-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks pare big early gains</a></h4><ul>\n<li>The major averages remain in the green, but are well off of session highs. The S&amp;P 500 and DJIA are <font color=\"green\">higher by 0.8%</font>, and the Nasdaq <font color=\"green\">by 1.25%</font>.</li>\n<li>The most notable patches of red are showing up in the consumer goods sector, with Coca-Cola <font color=\"red\">down 2.5%</font>, Pepsi <font color=\"red\">3.2%</font>, and Procter &amp; Gamble <font color=\"red\">1.8%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413958\" data-linked=\"Stocks pare big early gains\" data-tweet=\"Stocks pare big early gains https://seekingalpha.com/news/3413958-stocks-pare-big-early-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3413958-stocks-pare-big-early-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413956\" data-ts=\"1543853566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNSS\" target=\"_blank\">SNSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413956-sunesis-pharma-down-34-on-vecabrutinib-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunesis Pharma down 34% on vecabrutinib data</a></h4><ul> <li>Thinly traded nano cap Sunesis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a> <font color=\"red\">-33.5%</font>) is down on over four times normal volume, albeit on turnover of only 544K shares, following its <a href=\"https://seekingalpha.com/pr/17346503-sunesis-pharmaceuticals-announces-presentation-preliminary-data-phase-1b-2-trial-vecabrutinib\" target=\"_blank\">announcement </a>of preliminary data from a Phase 1b/2 clinical trial evaluating vecabrutinib, a non-covalent BTK inhibitor, in patients with relapsed/refractory chronic lymphocytic leukemia &#40;CLL&#41; and other blood cancers. The results were presented at ASH in San Diego.</li> <li>The data were generated on 11 patients (seven with CLL, two with mantle cell lymphoma and two with Waldenstrom macroglobulinemia) who had received an average of five prior lines of therapy and had progressed on prior covalent BTK inhibitor treatment.</li> <li>No efficacy data were presented. According to interim CEO Dayton Misfeldt, \"vecabrutinib has demonstrated both an encouraging safety profile and evidence of pharmacodynamic activity.\"</li> <li>On the safety front, the most common serious treatment-emergent adverse events were anemia, neutropenia, leukocytosis and ALT (liver enzyme) increase (10% each). One patient experienced a dose-limiting toxicity.</li> <li>#ASH18</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413956\" data-linked=\"Sunesis Pharma down 34% on vecabrutinib data\" data-tweet=\"$SNSS - Sunesis Pharma down 34% on vecabrutinib data https://seekingalpha.com/news/3413956-sunesis-pharma-down-34-on-vecabrutinib-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3413956-sunesis-pharma-down-34-on-vecabrutinib-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413957\" data-ts=\"1543853536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISCA\" target=\"_blank\">DISCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413957-discovery-top-loser-after-ratings-comments-from-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Discovery a top loser after ratings comments from CEO</a></h4><ul>   <li>Discovery (<a href=\"http://seekingalpha.com/symbol/DISCA\" target=\"_blank\">DISCA</a> <font color=\"red\">-6.8%</font>) is the S&amp;P 500's top laggard this morning following comments from its CEO about ratings on its flagship channel.</li>    <li>Speaking to a UBS conference, David Zaslav said \"we had some issues\" with the Discovery Channel that will crimp advertising.</li>    <li>On advertising, Zaslav says \"we had said that we would be three to five. And I think we're going to be a little less than that.\"</li>    <li>Some of the challenge on Discovery is due to production issues with auto show <i>Fast N' Loud,</i> he says. \"So a show that was supposed to come back on Monday night and carry on Monday night, won't be coming back until early next year.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413957\" data-linked=\"Discovery a top loser after ratings comments from CEO\" data-tweet=\"$DISCA $DISCB $DISCK - Discovery a top loser after ratings comments from CEO https://seekingalpha.com/news/3413957-discovery-top-loser-after-ratings-comments-from-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3413957-discovery-top-loser-after-ratings-comments-from-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413955\" data-ts=\"1543853191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDC\" target=\"_blank\">BDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413955-beldenminus-2_5-goldman-cuts-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Belden -2.5% as Goldman cuts to Neutral</a></h4><ul>   <li>Belden (NYSE:<a href='https://seekingalpha.com/symbol/BDC' title='Belden Inc.'>BDC</a>) is <font color=\"red\">2.5% lower</font> after Goldman Sachs cut its rating to Neutral, from Buy.</li>    <li>Anlyst Mark Delaney trimmed his price target to $55 from $69, now almost even with current pricing of $54.41.</li>    <li>Shares in Belden are <font color=\"green\">up 1.8%</font> over the past six months, but are still <font color=\"red\">down 27.7%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413955\" data-linked=\"Belden -2.5% as Goldman cuts to Neutral\" data-tweet=\"$BDC - Belden -2.5% as Goldman cuts to Neutral https://seekingalpha.com/news/3413955-beldenminus-2_5-goldman-cuts-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3413955-beldenminus-2_5-goldman-cuts-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413954\" data-ts=\"1543853121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413954-tesaro-leads-healthcare-gainers-aphria-and-tonix-pharmaceuticals-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesaro leads Healthcare gainers; Aphria and Tonix Pharmaceuticals among losers</a></h4><ul> <li>\n<b>Gainers: </b>Tesaro (NASDAQ:<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a>) <font color=\"green\">+59%</font>. Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a>) <font color=\"green\">+53%</font>. Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a>) <font color=\"green\">+36%</font>. Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>) <font color=\"green\">+16%</font>. Vanda Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a>) <font color=\"green\">+15%</font>.</li> <li>\n<b>Losers: </b>Sienna Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNNA' title='Sienna Biopharmaceuticals'>SNNA</a>) <font color=\"red\">-30%</font>. Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-25%</font>. Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"red\">-24%</font>. Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-24%</font>. Realm Therapeutics (<a href='https://seekingalpha.com/symbol/RLM' title='Realm Therapeutics PLC'>RLM</a>) <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413954\" data-linked=\"Tesaro leads Healthcare gainers; Aphria and Tonix Pharmaceuticals among losers\" data-tweet=\"$TSRO $TSRO $ATOS - Tesaro leads Healthcare gainers; Aphria and Tonix Pharmaceuticals among losers https://seekingalpha.com/news/3413954-tesaro-leads-healthcare-gainers-aphria-and-tonix-pharmaceuticals-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3413954-tesaro-leads-healthcare-gainers-aphria-and-tonix-pharmaceuticals-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413953\" data-ts=\"1543853081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413953-grouponplus-1_6-on-amc-integration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon +1.6% on AMC integration</a></h4><ul>\n<li>Groupon (NASDAQ:<a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a>) <a href=\"https://seekingalpha.com/pr/17347379-groupon-goes-movies-announces-distribution-partnership-amc-theatres\" target=\"_blank\">announces</a> a distribution partnership with AMC (NYSE:<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a>) that will give Groupon marketplace users greater access to movies through AMC's theaters.</li>\n<li>The integration will launch in 1H19, and the companies will continue to explore long-term opportunities to collaborate.</li>\n<li>Groupon shares are <font color=\"green\">up 1.6%</font> to $3.12.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413953\" data-linked=\"Groupon +1.6% on AMC integration\" data-tweet=\"$GRPN $GRPN $AMC - Groupon +1.6% on AMC integration https://seekingalpha.com/news/3413953-grouponplus-1_6-on-amc-integration?source=tweet\" data-url=\"https://seekingalpha.com/news/3413953-grouponplus-1_6-on-amc-integration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413948\" data-ts=\"1543852486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413948-ftc-clears-gamestops-spring-mobile-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTC clears GameStop&#39;s Spring Mobile sale</a></h4><ul> <li>The FTC grants antitrust clearance for GameStop's (<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color='green'>+0.8%</font>) $700M sale of the Spring Mobile business to Prime Communications.</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3411687-gamestop-sell-spring-mobile-700m-updated\" target=\"_blank\">GameStop to sell Spring Mobile for $700M (updated)</a> (Nov. 21)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3413948\" data-linked=\"FTC clears GameStop&#39;s Spring Mobile sale\" data-tweet=\"$GME - FTC clears GameStop&#39;s Spring Mobile sale https://seekingalpha.com/news/3413948-ftc-clears-gamestops-spring-mobile-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3413948-ftc-clears-gamestops-spring-mobile-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413945\" data-ts=\"1543852309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSANY\" target=\"_blank\">NSANY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413945-nissan-u-s-sales-down-18_7-in-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nissan U.S. sales down 18.7% in November</a></h4><ul>\n<li>Nissan (<a href='https://seekingalpha.com/symbol/NSANY' title='Nissan Motor Co., Ltd.'>OTCPK:NSANY</a>) unit sales <a href=\"https://nissannews.com/en-US/nissan/usa/channels/U-S-Sales-Reports/releases/nissan-group-reports-november-2018-us-sales\" sasource=\"qp_sum_news_20\" target=\"_blank\">-18.7%</a> to 110,513 units vs. -16.3% forecast by Edmunds.</li>\n<li>Nissan truck sales dropped 8.4% Y/Y to 72,856 units.</li>\n<li>Nissan car sales slipped 33.3% to 37,657 units.</li>\n<li>Sales growth by brand: Nissan -21.6% to 96,427 units; Infiniti +8.1% to 14,086 units.</li>\n<li>Rogue sales down 11.7% to 31,860 units during the month.</li>\n<li>Sentra decreased 27.6% to 12,721 units.</li>\n<li>YTD Nissan sales fell 7.6% to 1,345,157 units.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413945\" data-linked=\"Nissan U.S. sales down 18.7% in November\" data-tweet=\"$NSANY - Nissan U.S. sales down 18.7% in November https://seekingalpha.com/news/3413945-nissan-u-s-sales-down-18_7-in-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3413945-nissan-u-s-sales-down-18_7-in-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413943\" data-ts=\"1543852258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNNA\" target=\"_blank\">SNNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413943-sienna-bios-pegcantratinib-flunks-mid-stage-psoriasis-study-shares-down-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sienna Bio&#39;s pegcantratinib flunks mid-stage psoriasis study; shares down 27%</a></h4><ul> <li>Thinly traded micro cap Sienna Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/SNNA' title='Sienna Biopharmaceuticals'>SNNA</a> <font color=\"red\">-27.2%</font>) is down on average volume following its <a href=\"https://seekingalpha.com/pr/17346775-sienna-biopharmaceuticals-announces-topical-non-steroidal-trka-inhibitor-snaminus-120-0_05\" target=\"_blank\">announcement </a>of topline data from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03448081?spons=sienna&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2b clinical trial</a> evaluating SNA-120 (pegcantratinib) in patients with mild-to-moderate psoriasis with at least moderate pruritis (itchy skin).</li> <li>The study failed to achieve the primary endpoint of the change from baseline to week 8 in a scale of pruritis severity called I-NRS. Specifically, patients treated with SNA-120 experienced a mean 4.3-point reduction in I-NRS compared to a 4.0-point reduction for vehicle (placebo) (p=0.244). The results were similar between the 0.05% and 0.5% strengths.</li> <li>On a positive note, 27% of treated patients achieved a 75% reduction in lesions (PASI 75) compared to 13% for vehicle (p=0.045).</li> <li>No safety signals were observed.</li> <li>A Phase 3 study assessing SNA-120 in psoriasis and a Phase 2 study assessing SNA-125 in atopic dermatitis should launch in H2 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413943\" data-linked=\"Sienna Bio&#39;s pegcantratinib flunks mid-stage psoriasis study; shares down 27%\" data-tweet=\"$SNNA - Sienna Bio&#39;s pegcantratinib flunks mid-stage psoriasis study; shares down 27% https://seekingalpha.com/news/3413943-sienna-bios-pegcantratinib-flunks-mid-stage-psoriasis-study-shares-down-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3413943-sienna-bios-pegcantratinib-flunks-mid-stage-psoriasis-study-shares-down-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413941\" data-ts=\"1543851666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413941-macau-names-in-rally-mode\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau names in rally mode</a></h4><ul> <li>Macau casino stocks are sharply higher after revenue for November came in ahead of estimates.</li> <li>Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+9.9%</font>), Melco Resorts &amp; Entertainment (<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a> <font color='green'>+7.8%</font>), Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='green'>+6.7%</font>), Studio City International (<a href='https://seekingalpha.com/symbol/MSC' title='Studio City International Holdings'>MSC</a> <font color='green'>+6.4%</font>) and MGM Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='green'>+4.1%</font>) are also benefiting from the cooling off of U.S.-China trade tensions.</li> <li>Union Gaming sys the most likely scenario in Macau remains a \"decent mass market\" story with low double-digit growth and a \"mixed VIP story\" with modest growth. \"Looking ahead to 1Q19, we expect a slow start to the year with the whole of 1Q19 at +3% before picking up into the mid-single digits post 1Q,\" writes analyst Grant Govertsen.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3413710-macau-casino-revenue-shines-november\" target=\"_blank\">Macau casino revenue shines in November</a> (Dec. 1)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413941\" data-linked=\"Macau names in rally mode\" data-tweet=\"$WYNN $WYNN $MLCO - Macau names in rally mode https://seekingalpha.com/news/3413941-macau-names-in-rally-mode?source=tweet\" data-url=\"https://seekingalpha.com/news/3413941-macau-names-in-rally-mode\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413931\" data-ts=\"1543850588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAV\" target=\"_blank\">NAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413931-cerberus-takes-majority-stake-in-navistars-defense-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cerberus takes majority stake in Navistar&#39;s defense business</a></h4><ul> <li>Cerberus Capital strikes a deal to acquire a 70% stake in Navistar's (<a href='https://seekingalpha.com/symbol/NAV' title='Navistar International Corporation'>NAV</a> <font color='green'>+1.4%</font>) defense business.</li>\n<li>\"Today's announcement is a strategic milestone for Navistar Defense as it provides the business with a well-established, long-term partner that is focused on making crucial growth investments in the business,\" says Navistar COO Persio Lisboa,</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/17347346-cerberus-acquire-majority-interest-navistar-defense\" target=\"_blank\">Press Release</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413931\" data-linked=\"Cerberus takes majority stake in Navistar&#39;s defense business\" data-tweet=\"$NAV - Cerberus takes majority stake in Navistar&#39;s defense business https://seekingalpha.com/news/3413931-cerberus-takes-majority-stake-in-navistars-defense-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3413931-cerberus-takes-majority-stake-in-navistars-defense-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413929\" data-ts=\"1543850505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413929-nvidia-unveils-t-rex-gpu\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia unveils T-Rex GPU</a></h4><ul> <li>Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) <a href=\"https://seekingalpha.com/pr/17346833-nvidia-reveals-titan-turing-titan-rtx\" target=\"_blank\">unveils</a> the Titan RTX GPU that's capable of 130 teraflops of compute power and 11 GigaRays a second of ray-tracing performance.</li> <li>Other tech specs from Nvidia: 576 multi-precision Turing Tensor Cores, 72 Turing RT Cores, and 24GB of high-speed GDDR6 memory with 672GB/s of bandwidth (2x previous gen).</li> <li>The Titan RTX, nicknamed T-Rex, follows the Titan V from December 2017, which could achieve 110 teraflops of compute power.</li> <li>T-Rex will be available later this month in the U.S. and Europe for $2,499.</li> <li>Nvidia shares are <font color=\"green\">up 5%</font> to $171.69.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413929\" data-linked=\"Nvidia unveils T-Rex GPU\" data-tweet=\"$NVDA - Nvidia unveils T-Rex GPU https://seekingalpha.com/news/3413929-nvidia-unveils-t-rex-gpu?source=tweet\" data-url=\"https://seekingalpha.com/news/3413929-nvidia-unveils-t-rex-gpu\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413925\" data-ts=\"1543850419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSCO\" target=\"_blank\">TSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413925-oppenheimer-warns-on-tractor-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer warns on Tractor Supply</a></h4><ul> <li>Oppenheimer lowers Tractor Supply (<a href='https://seekingalpha.com/symbol/TSCO' title='Tractor Supply Company'>TSCO</a> <font color='red'>-0.5%</font>) to a Perform rating from Outperform due to the risk of lower oil prices.</li> <li>\"Oil prices have tended to represent a key top-line driver for TSCO. While we continue to look favorably upon the underlying operating prowess of TSCO and believe that while many internal and external drivers for the company remain solidly in place, we are increasingly concerned that now much weaker oil prices could limit the potential for sales and hence EPS upside in coming quarters,\" updates Oppenheimer.</li> <li>The firm assigns a price target of $100 on TSCO.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413925\" data-linked=\"Oppenheimer warns on Tractor Supply\" data-tweet=\"$TSCO - Oppenheimer warns on Tractor Supply https://seekingalpha.com/news/3413925-oppenheimer-warns-on-tractor-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/3413925-oppenheimer-warns-on-tractor-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413923\" data-ts=\"1543850060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413923-janssen-affiliate-teams-up-argenx-to-develop-cancer-candidate-cusatuzumab\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Janssen affiliate teams up with argenx to develop cancer candidate cusatuzumab</a></h4><ul> <li>Cilag GmbH, an affiliate of Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-0.8%</font>) unit Janssen Pharmaceutical, inks a global collaboration and license agreement with argenx BVBA and argenx SE (<a href='https://seekingalpha.com/symbol/ARGX' title='Argenx SE'>ARGX</a> <font color=\"green\">+12.3%</font>) to develop and commercialize cusatuzumab, an anti-CD70 <a href=\"https://www.argenx.com/en-GB/content/simple-antibody-platform/23/\" target=\"_blank\">SIMPLE Antibody</a>, for a range of cancers.</li> <li>A Phase 1/2 trial is underway in patients with acute myeloid leukemia &#40;AML&#41; and high-risk myelodysplastic syndromes &#40;MDS&#41;.</li> <li>Under the terms of the deal, Janssen will pay $300M upfront, milestones and double-digit royalties on net ex-U.S. sales. The companies will equally share costs and profits/losses in the U.S.  Janssen will be responsible for global commercialization while argenx has the option to participate in commercialization in the U.S.</li> <li>The transaction should close next quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413923\" data-linked=\"Janssen affiliate teams up with argenx to develop cancer candidate cusatuzumab\" data-tweet=\"$JNJ $JNJ $ARGX - Janssen affiliate teams up with argenx to develop cancer candidate cusatuzumab https://seekingalpha.com/news/3413923-janssen-affiliate-teams-up-argenx-to-develop-cancer-candidate-cusatuzumab?source=tweet\" data-url=\"https://seekingalpha.com/news/3413923-janssen-affiliate-teams-up-argenx-to-develop-cancer-candidate-cusatuzumab\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413917\" data-ts=\"1543849663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISH\" target=\"_blank\">DISH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413917-dish-network-tegna-end-short-blackout-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish Network, Tegna end short blackout with deal</a></h4><ul>   <li>After no-commenting a retransmission dispute with Tegna (<a href=\"http://seekingalpha.com/symbol/TGNA\" target=\"_blank\">TGNA</a> <font color=\"red\">-1.4%</font>), Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>) is <font color=\"green\">up 1.8%</font> this morning after saying the issue has been resolved.</li>    <li>A blackout of Tegna's 49 local channels on Dish systems quickly ended over the weekend after the two reached a multi-year carriage agreement.</li>    <li>Meanwhile, Dish and HBO are <a href=\"https://seekingalpha.com/news/3404105-hbo-blacked-first-time-dish-network-t-lock-horns-updated\" target=\"_blank\">still at loggerheads in a blackout</a> that is now a month old.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413917\" data-linked=\"Dish Network, Tegna end short blackout with deal\" data-tweet=\"$DISH $DISH $TGNA - Dish Network, Tegna end short blackout with deal https://seekingalpha.com/news/3413917-dish-network-tegna-end-short-blackout-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3413917-dish-network-tegna-end-short-blackout-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413911\" data-ts=\"1543849314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413911-retail-outperformers-off-u-s-china-tariff-de-escalatation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail outperformers off U.S.-China tariff de-escalatation</a></h4><ul> <li>The cooling off of U.S.-China trade tensions is helping to lift a number of retail stocks. The gains in some cases are just a recovery of a risk premium tied to the risk of higher tariffs (proposed for January 1) cutting into profitability.</li> <li>Notable gainers include Ascena Retail (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+2.3%</font>), Williams-Sonoma (<a href='https://seekingalpha.com/symbol/WSM' title='Williams-Sonoma Inc.'>WSM</a> <font color='green'>+3.3%</font>), Tiffany (<a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a> <font color='green'>+4.6%</font>), Boot Barn (<a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings'>BOOT</a> <font color='green'>+2.8%</font>), Zagg (<a href='https://seekingalpha.com/symbol/ZAGG' title='ZAGG Inc'>ZAGG</a> <font color='green'>+6.3%</font>), Floor &amp; Decor (<a href='https://seekingalpha.com/symbol/FND' title='Floor & Decor Holdings, Inc.'>FND</a> <font color='green'>+3.9%</font>), RH (<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='green'>+1.9%</font>), G-III Apparel (<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='green'>+9.3%</font>), Canada Goose (<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+3.2%</font>), Ralph Lauren (<a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a> <font color='green'>+2.7%</font>), Lululemon (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+2.4%</font>), Skechers (<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+3.4%</font>), PVH (<a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a> <font color='green'>+4.8%</font>), Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co.'>BBY</a> <font color='green'>+3.4%</font>), Michael Kors (KORS <font color='green'>+3.4%</font>), Fossil (<a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+3.8%</font>), Tapestry (<a href='https://seekingalpha.com/symbol/TPR' title='Tapestry, Inc.'>TPR</a> <font color='green'>+3.3%</font>) and Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+3.9%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3413911\" data-linked=\"Retail outperformers off U.S.-China tariff de-escalatation\" data-tweet=\"$ASNA $ASNA $WSM - Retail outperformers off U.S.-China tariff de-escalatation https://seekingalpha.com/news/3413911-retail-outperformers-off-u-s-china-tariff-de-escalatation?source=tweet\" data-url=\"https://seekingalpha.com/news/3413911-retail-outperformers-off-u-s-china-tariff-de-escalatation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413907\" data-ts=\"1543849081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413907-ebixminus-2-on-kase-conference-short-pitch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ebix -2% on Kase conference short pitch</a></h4><ul>\n<li>Presenting at the Kase Learning Short-Selling Conference, Viceroy Research says it's short Ebix (<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a> <font color='red'>-2.4%</font>).</li>\n<li>Noted are previous run-ins with the SEC, accounting irregularities, six auditors in 12 years, assets shuffling around, a poison pill, and a switched story from insurance to finance.</li>\n<li>Shares <font color=\"red\">down 2.15%</font>.</li>\n<li>#KaseLearning</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413907\" data-linked=\"Ebix -2% on Kase conference short pitch\" data-tweet=\"$EBIX - Ebix -2% on Kase conference short pitch https://seekingalpha.com/news/3413907-ebixminus-2-on-kase-conference-short-pitch?source=tweet\" data-url=\"https://seekingalpha.com/news/3413907-ebixminus-2-on-kase-conference-short-pitch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413905\" data-ts=\"1543848992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413905-vanda-pharma-up-16-on-positive-tradipitant-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanda Pharma up 16% on positive tradipitant data</a></h4><ul> <li>Vanda Pharmaceuticals (<a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a> <font color=\"green\">+16.3%</font>) is up on below-average volume in early trade following its <a href=\"https://seekingalpha.com/pr/17346650-vanda-announces-positive-phase-ii-study-results-tradipitant-patients-gastroparesis\" target=\"_blank\">announcement </a>of successful results from a 141-subject <a href=\"https://clinicaltrials.gov/ct2/show/NCT02970968?lead=vanda+pharmaceuticals&amp;phase=1&amp;rank=2\" target=\"_blank\">Phase 2 clinical trial</a> evaluating tradipitant in patients with idiopathic (cause unknown) and diabetic gastroparesis.</li> <li>The study met the primary endpoint of change in nausea score versus placebo (-1.2 vs. -0.7; p=0.0099). Patients in the treatment group also experienced a statistically significant improvement in the proportion of nausea-free days compared to control (28.8% vs. 15.0%; p=0.0160).</li> <li>On the safety front, tolerability was similar between tradipitant and placebo.</li> <li>The company plans to meet with regulatory authorities to clarify a path to registration.</li> <li>Vanda in-licensed the neurokinin 1 antagonist from Eli Lilly in 2012.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3295284-vandas-tradipitant-shows-mixed-results-mid-stage-dermatitis-study\" target=\"_blank\">Vanda's tradipitant shows mixed results in mid-stage dermatitis study</a> (Sept. 13, 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413905\" data-linked=\"Vanda Pharma up 16% on positive tradipitant data\" data-tweet=\"$VNDA - Vanda Pharma up 16% on positive tradipitant data https://seekingalpha.com/news/3413905-vanda-pharma-up-16-on-positive-tradipitant-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3413905-vanda-pharma-up-16-on-positive-tradipitant-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413904\" data-ts=\"1543848952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HX\" target=\"_blank\">HX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413904-hexindai-slides-18_2-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hexindai slides 18.2% post Q2 results</a></h4><ul> <li>Hexindai (<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a> <font color=\"red\">-18.2%</font>) <a href=\"https://seekingalpha.com/pr/17346817-hexindai-reports-unaudited-second-quarter-fiscal-year-2019-financial-results\" target=\"_blank\"><u>reports Q2</u></a> revenue decreased 82.9% Y/Y to $3.62M.</li> <li>Total loan volume facilitated was $33.8M, a decrease of 87.4% Y/Y.</li> <li>Gross billing amount was $4.9M, a decrease of 79.3% Y/Y.</li> <li>Gross billing ratio for credit loans was 14.4%, an increase from 9% during Q2 2018.</li> <li>Number of borrowers<sup> </sup>was 2,183, a decrease of 89.5% Y/Y.</li> <li>Number of investors<sup> </sup>was 38,825, a decrease of 9.2% Y/Y.</li> <li>Operating expenses was $21.1M (+222.1% Y/Y); the significant increase was due to an increase in S&amp;M, G&amp;A expenses and SBC.</li>\n<li>Cash and equivalents of $53.1M.</li>\n<li>\n<strong>Q3 2019 Outlook:</strong> Total loans facilitated will be $56-60M &amp; Net revenue of $1.4-1.6M.</li> <li>\n<strong>2019 Outlook:</strong> Total loans facilitated will be $700-720M &amp; Net revenue of $66-70M.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3413817-hexindai-reports-q2-results\" target=\"_blank\">Hexindai reports Q2 results</a> (Dec. 03 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3413904\" data-linked=\"Hexindai slides 18.2% post Q2 results\" data-tweet=\"$HX - Hexindai slides 18.2% post Q2 results https://seekingalpha.com/news/3413904-hexindai-slides-18_2-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3413904-hexindai-slides-18_2-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413897\" data-ts=\"1543848329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLNX\" target=\"_blank\">XLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413897-keybanc-boosts-xilinx-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc boosts its Xilinx target</a></h4><ul>\n<li>KeyBanc <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Xilinx+%28XLNX%29+PT+Raised+to+%24100+at+KeyBanc/14882874.html\" target=\"_blank\">maintains</a> an Overweight rating on Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>) and raises the target from $90 to $100.</li>\n<li>Last week, analyst Weston Twigg <a href=\"https://finance.yahoo.com/news/keybanc-sees-significant-runway-amd-200527312.html\" target=\"_blank\">wrote</a>: \"XLNX remains well-positioned to gain additional share as beta programs conclude, and we remain positive on its long-term growth potential in the cloud.\"</li>\n<li>Xilinx shares are <font color=\"green\">up 1.9%</font> to $94.20.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413897\" data-linked=\"KeyBanc boosts its Xilinx target\" data-tweet=\"$XLNX - KeyBanc boosts its Xilinx target https://seekingalpha.com/news/3413897-keybanc-boosts-xilinx-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3413897-keybanc-boosts-xilinx-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413896\" data-ts=\"1543848176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDSN\" target=\"_blank\">HDSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413896-hudson-soars-on-cash-flow-achievement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hudson soars on cash flow achievement</a></h4><ul>\n<li>Hudson Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies, Inc.'>HDSN</a>) <font color=\"green\">+56%</font> in early trade after disclosing late Friday that it entered into definitive amendments to its term loan and revolving loan credit facilities.</li>\n<li>\"In the first nine months of 2018 we drove strong cash flow from operations of $35M and reduced our debt by $37M,\" CEO Kevin Zugibe added. \"These definitive amendments with our lenders provide amended covenants that give us the financial flexibility and liquidity to drive our operating performance and support our long-term corporate objectives as we look toward the 2019 selling season and beyond.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3413896\" data-linked=\"Hudson soars on cash flow achievement\" data-tweet=\"$HDSN - Hudson soars on cash flow achievement https://seekingalpha.com/news/3413896-hudson-soars-on-cash-flow-achievement?source=tweet\" data-url=\"https://seekingalpha.com/news/3413896-hudson-soars-on-cash-flow-achievement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3413894\" data-ts=\"1543847988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRHC\" target=\"_blank\">TRHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3413894-tabula-rasa-to-acquire-dosing-software-developer-doseme-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tabula Rasa to acquire dosing software developer DoseMe; shares up 3%</a></h4><ul><li>Tabula Rasa (<a href='https://seekingalpha.com/symbol/TRHC' title='Tabula Rasa HealthCare'>TRHC</a> <font color=\"green\">+2.8%</font>) has <a href=\"https://seekingalpha.com/pr/17346921-tabula-rasa-healthcare-acquire-doseme-precision-dosing-software-company\" target=\"_blank\">agreed to acquire</a> Brisbane, Australia-based DoseMe, a developer of a dosing tool called <a href=\"https://doseme-rx.com/\" target=\"_blank\">DoseMeRx</a>, for an undisclosed sum.</li></ul><div class=\"tiny-share-widget\" data-id=\"3413894\" data-linked=\"Tabula Rasa to acquire dosing software developer DoseMe; shares up 3%\" data-tweet=\"$TRHC - Tabula Rasa to acquire dosing software developer DoseMe; shares up 3% https://seekingalpha.com/news/3413894-tabula-rasa-to-acquire-dosing-software-developer-doseme-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3413894-tabula-rasa-to-acquire-dosing-software-developer-doseme-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}